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ABSTRACT 
 
Campylobacteriosis is one of the leading foodborne illnesses in United States, and is 
associated with the consumption of poultry and poultry products. Reducing Campylobacter in 
these species will reduce the burden of this disease. Unfortunately, most strategies employed to 
reduce Campylobacter in poultry have either not been successful or produced inconsistent 
results. One potential control strategy is the use of β-resorcylic acid (BR), a phytophenolic 
compound classified by the US FDA as “Everything Added to Food in the United States” (EAF 
3045) and is therefore deemed safe for consumption. This compounds has antibacterial activity 
against Salmonella, however, its efficacy to control Campylobacter in poultry has not been 
evaluated. Preliminary studies in our laboratory demonstrated that BR kills Campylobacter 
jejuni, in vitro. Therefore, the objective of this study was to evaluate if BR would reduce 
Campylobacter in chickens. In pre-harvest studies, day of hatch chicks were fed one of five 
treatments (0, 0.25, 0.5, 1 or 2%BR) in the first trial, whereas a second trial was conducted 
including two additional doses of 0.75% & 1.5% BR (n=10 chicks/dose). Birds were challenged 
with mixture of four wild strains of C. jejuni (~ 106 CFU/mL) on day 7 and cecal samples were 
collected on day 14 and enumerated for Campylobacter. In post-harvest studies, four trials, two 
each on thigh skin and breast meat, were conducted. Chicken skin or meat samples (2±0.1g) 
were inoculated with 50µL of C. jejuni (~ 107 CFU/mL).  Following 30 min of attachment, 
samples were dipped into their respective treatment solutions (0, 0.5, 1, 2% BR) for 30 s and 
suspended 2 min (n=10 samples/dose) and evaluated for reduction in Campylobacter counts. 
Campylobacter counts were reduced by 1.4 Log CFU/g for the 2% dose in the first pre-harvest 
trial and by 4.2 or 2.8 Log CFU/g for the 0.5 % & 1% BR doses in the second pre-harvest trial 
(P<0.05).  In the post-harvest studies, all doses of BR significantly reduced Campylobacter 
counts in both meat and skin. Results of these experiments suggest post-harvest application of 
BR is the most effective treatment and may help reduce the incidence of human 
campylobacteriosis. 
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INTRODUCTION 
Foodborne diseases are a growing public health concern and Campylobacter is one of the 
leading causes of bacterial foodborne illnesses (WHO, 2012; CDC, 2014). The Centers for 
Disease Control and Prevention (CDC) estimated the incidence of campylobacteriosis to be 
13.83 per 100,000 humans with a loss of $ 1.7 billion per annum (Hoffmann, et al., 2012; CDC, 
2014). In the European Union, approximately 9 million cases annually of human 
campylobacteriosis are estimated resulting in a € 2.4 billion economic cost (EFSA Panel on 
Biological Hazards, 2011). Campylobacter infections in humans is also implicated in causing 
Guillain-Barré syndrome, reactive arthritis and irritable bowel syndrome (Berden, et al., 1979; 
Rhodes and Tattersfield, 1982; Smith, 2002; Pope, et al., 2007; Gradel, et al., 2009). Risk 
assessment studies on Campylobacter identified poultry and poultry products as a major source 
of human infections (Rosenquist, et al., 2003; Friedman, et al., 2004; FAO/WHO, 2009). Source 
attribution studies indicated handling of raw chicken, consumption of undercooked meat and 
cross-contamination during food preparation are likely causes for human Campylobacter 
infections (Hopkins and Scott, 1983; Altekruse, et al., 1999; Friedman, et al., 2004; Danis, et al., 
2009; Lindmark, et al., 2009; Fajo-Pascual, et al., 2010). Campylobacter jejuni has been reported 
as the most common species causing campylobacteriosis (Friedman, 2000; FAO/WHO, 2009) 
and is the most common species found in poultry (Suzuki and Yamamoto, 2009). It has been 
estimated that a reduction of Campylobacter counts by 2 Log on chicken carcasses will reduce 
the incidence of this disease causing bacterium in humans by 30 fold (Rosenquist, et al., 2003). 
Therefore, the aim of this thesis research is to reduce Campylobacter in both pre-harvest and 
post-harvest poultry by using the novel compound, β-resorcylic acid. 
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HISTORICAL PERSPECTIVE 
A non-culturable and spiral bacteria was first observed by Theodore Escherich in the 
colon of children who died from cholera infantum (Escherich, 1886).  The first isolation of a 
Vibrio-like organism from ovine aborted fetuses was accomplished by two veterinary surgeons, 
McFadyean and Stockman in 1913 (Butzler, 2004; Skirrow, 2006; Debruyne, et al., 2008). Smith 
and Taylor (1919) found similar organisms associated with diseased fetal membranes in cattle 
and proposed the name Vibrio fetus.  The term, Vibrio jejuni (Jones and Little, 1931) and Vibrio 
coli (Doyle, 1944) were given to a group of similar bacteria causing winter dysentery in calves 
and swine dysentery, respectively (Jones, et al., 1931; Doyle, 1944). 1n 1946, Levy noted the 
presence of spiral organisms microscopically in the blood of people with gastrointestinal disease 
but was unable to recover by culture (Levy, 1946). Vinzent and colleagues (1947) successfully 
isolated Vibrio fetus from the blood of a pregnant woman suffering from fever of unknown 
origin in the following year. King first studied the strains of Vibrio and described a new strain 
with different antigenic and biochemical characteristic but several common features with the 
agent reported by Vinzent (King, 1957; King, 1962). In 1963, Sebald and Véron proposed the 
new genus Campylobacter separating them from true Vibrio due to their low DNA base 
composition, microaerophilic growth requirements and nonfermentative metabolism (Sebald and 
Véron, 1963). Isolation of Campylobacter from human feces was first accomplished in 1968 and 
the significance of genus members as human enteric pathogens was elucidated (Dekeyser, et al., 
1972; Skirrow, 1977). Additional organisms identified in 1973 as Vibrio-like microaerophilic 
bacteria were classified under the same genus Campylobacter including Vibrio jejuni and Vibrio 
coli (Butzler, 2004). The genus Campylobacter later was incorporated into a new family, 
Campylobacteraceae, along with other genera; Helicobacter, Arcobacter, Sulfurospirillum, and 
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Wolinella (Debruyne, et al., 2008). Campylobacter species are the most common bacterial cause 
of diarrhea worldwide as was determined by the mid to end 1980s (Allos, 2001). Currently, there 
are 17 species of Campylobacter under the genus Campylobacter (Lastovica, 2006; Debruyne, et 
al., 2008). Campylobacter jejuni and Campylobacter coli account for over 95% of the human 
Campylobacter infections (Park, 2002; Snelling, et al., 2005).  
CHARACTERISTICS OF CAMPYLOBACTER 
Morphological characteristics 
The word Campylobacter is made of up two Greek words, “kampulos” meaning “curved” 
and “bacter” meaning “rod” (Sebald and Véron, 1963). Members of the genus Campylobacter 
are gram negative, non-spore forming, mostly slender, spirally curved rods 0.2 to 0.8μm wide 
and 0.5 to 5μm long (Thomas, et al., 1998; Debruyne, et al., 2008). This bacterium can also 
transform into a coccoid viable but nonculturable (VBNC) state under unfavorable conditions 
(Rollins and Colwell, 1986). Most species are motile with characteristic cork-screw-like motion 
by means of long, single, polar flagellum two to three times the length of cells (Smibert, 1978; 
Debruyne, et al., 2008). Some exceptions are C. gracilis, which is nonmotile, and C. showae, 
which have multiple flagella (Debruyne, et al., 2008).  
Growth requirements 
Most of the Campylobacter spp are nutritionally fastidious and require a microaerophilic 
environment for growth (Kelly, 2001; Park, 2002; Garénaux, et al., 2008). Some species are 
almost anaerobic, however, the majority are microaerophilic growing optimally in the presence 
of 5-10% oxygen (Thomas, et al., 1998; Park, 2002). They need a complex media with additional 
growth supplements for culture (Buck and Smith, 1987; Kelly, 2001). Furthermore, thermophilic 
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Campylobacters have restricted growth temperature requirements, optimally growing at 42°C 
and not below 30°C (Thomas, et al., 1998; Park, 2002; Jackson, et al., 2009). However, C. jejuni 
displays physiological activity even at 4°C (Hazeleger, et al., 1998). Campylobacter jejuni 
undergoes a morphological change from spiral to coccoid form after several days of growth, in 
vitro (Kelly, 2001). Unfortunately, conditions like stress, temperature, pH, osmolarity, and 
medium are responsible for transition from spiral to coccoid VBNC state (Rollins and Colwell, 
1986; Lázaro, et al., 1999; Moore, 2001; Jackson, et al., 2009). The VBNC state, first described 
by Rollins and Colwell (1986), is a survival mechanism under unfavorable conditions in which 
the ability to culture is lost even though the microorganism is alive and metabolically active 
(Oliver, 2005; Svensson, et al., 2008). Campylobacter jejuni may enter the VBNC state due to 
abiotic stress making their detection difficult during quality control testing via culture methods 
and therefore creating a challenge for the food processing industry (Jackson, et al., 2009). Some 
studies have reported that these VBNC cells may still retain their ability to culture and to 
colonize or infect the host (Saha, et al., 1991; Cappelier, et al., 1999; Rowan, 2004; Baffone, et 
al., 2006) but not in other studies (Ziprin, et al., 1999; Hald, et al., 2001; Ziprin, et al., 2003). 
CAMPYLOBACTER IN HUMANS 
Sources of infection 
The reservoirs of thermophilic Campylobacter responsible for human infections 
comprises food production animals like chicken, turkey, ducks, cattle, sheep and pigs (Penner, 
1988; Skirrow, 1982; Blaser, 1997; Stanley and Jones, 2003; Stojanov, et al., 2004; Humphrey, 
et al., 2007) wild birds and reptiles (Luechtefeld, et al., 1980; Kapperud and Rosef, 1983; Harvey 
and Greenwood, 1985; Pacha, et al., 1987; Pacha, et al., 1988; Tresierra‐Ayala and Fernandez, 
1997). Water sources (e.g., ponds) and protozoan also can serve as reservoirs (Jones, 2001; 
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Axelsson-Olsson, et al., 2005). Chicken as a primary source of infection was mentioned by King 
(King, 1962; Skirrow, 1977) and presently constitute by far the largest potential source of human 
infections (Butzler, 2004). The handling and consumption of poultry are a major source of 
infections as reported and accepted worldwide in many studies (Hopkins and Scott, 1983; Ikram, 
et al., 1994; Altekruse, et al., 1999; Neimann, et al., 2003; Friedman, et al., 2004; Stafford, et al., 
2008; Danis, et al., 2009; Lindmark, et al., 2009; Fajo-Pascual, et al., 2010).  Cross-
contamination during food preparation is also significant risk factor (Boer and Hahne, 1990; 
Mylius, et al., 2007; Luber, 2009). Other sources are consumption of raw or unpasteurized milk 
(Porter and Reid, 1980; Robinson and Jones, 1981; Taylor, et al., 1982; Potter, et al., 1983; 
Kornblatt, et al., 1985; Peterson, 2003), fruits and vegetables (Evans, et al., 2003; Verhoeff-
Bakkenes, et al., 2011), untreated water (Vogt, et al., 1982; Palmer, et al., 1983; Taylor, et al., 
1983; Hopkins, et al., 1984; Sacks, et al., 1986; Melby, et al., 1991), mushrooms (Doyle and 
Schoeni, 1986) as well as direct transmission of Campylobacter from animals to humans (e.g., 
dogs; Rosef and Kapperud, 1983). Another possible route of infection is direct contact with 
domestic animals and pets (Deming, et al., 1987; Kapperud, et al., 1992; Studahl and Andersson, 
2000; Workman, et al., 2005).  
Human incidence  
With the development of a selective medium by Skirrow (1977) and methods by 
Dekeyser and coworkers (1972) to identify and isolate Campylobacter from human samples, a 
more accurate assessment of the disease burden is possible. Campylobacterisis remains an 
emerging foodborne disease globally since 1980s (WHO, 2012; EFSA, 2013; CDC, 2014). In the 
United States, the CDC estimated an incidence of 13.83/100,000 humans in 2013 which is 
significantly higher than data reported in 2006-2008 (CDC, 2014).  However, true incidence is 
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expected to be even higher because many cases are undiagnosed or underreported (Mead, et al., 
1999; Samuel, et al., 2004). In the European Union, campylobacteriosis was the most commonly 
reported zoonotic disease followed by salmonellosis in 2011 (EFSA/ECDC., 2013). The 
European Food Safety Authority and the European Centre for Disease Control and Prevention 
jointly reported 220,209 Campylobacter cases in 2011, 2.2% more than in 2010 (EFSA, 2013). 
Annual cases of 225,000 were estimated in Australia and 500,000 in England and Wales, (Hall, 
et al., 2008; Nichols, et al., 2012). Increasing incidences were also reported from the Netherlands 
(Havelaar, et al., 2012), Germany (Schielke, et al., 2014), Finland (Nakari, et al., 2010) and 
Israel (Weinberger, et al., 2013).  
The incidence of human campylobacteriosis has shown variation in regard to age, sex and 
season (Friedman, 2000; Nelson and Harris, 2011). The highest rates of cases were reported in 
infants and young adults in developed countries (Galanis, 2007; Schielke,et al., 2014). The 
incidence was 24.08 per 100,000 in infants (<5year) followed by 14.54 per 100,000 in the 20-64 
age group in the United States (CDC, 2014). Rates of Campylobacter infection are, in general, 
higher in males with approximate male to female ratio of 1.2 to 1 (Louis, et al., 2005; Olson, et 
al., 2008).  The reason behind this inequality was not fully explained (Friedman, 2000; Allos, 
2001). Studies in seasonality index for campylobacteriosis have stated a peaked incidence during 
June-August in North America, Europe, UK and Canada (Nylen, et al., 2002; Nelson and Harris, 
2011; Lal, et al., 2012). Seasonal distribution of Campylobacter incidence may correspond with 
the increased prevalence of Campylobacter in reservoirs and sources and also the seasonal 
variation in human behavior which exposes people to Campylobacters (Nylen, et al., 2002). In 
developing countries, the number of cases campylobacteriosis is unknown due to a lack of 
national surveillance programs (Coker, et al., 2002).   
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Pathogenesis of campylobacteriosis 
Even though there is significant knowledge about the clinical, microbiological and 
epidemiological aspects of Campylobacter infections, the molecular mechanisms involved in 
pathogenesis are still poorly understood (Ketley, 1997). The initiation and establishment of C. 
jejuni infection are thought to involve adherence, protein secretion, and invasion which can 
stimulate the host cell inflammatory response (Larson, et al., 2008). Its bacterial flagellum aids in 
infection by facilitating motility as well as secretion of Campylobacter invasion antigen (Dasti, 
et al., 2010). Binding of Campylobacter to a host cell is mediated by two fibronectin binding 
proteins, CadF and FlpA (Konkel, et al., 1997; Konkel, et al., 2010). Then, Campylobacter 
invasion antigen modify the host cell regulatory pathway and promote host cell invasion and 
intracellular survival (Konkel, et al., 1999; Konkel, et al., 2004). It has been reported that 
microtubules and microfilaments of host cells trigger the internalization of Campylobacter 
(Biswas, et al., 2003). Cytolethal distending toxins (Cdt A, B, C), major pathogenicity-associated 
factors, have been recognized recently that play a key role in arresting the cell cycle and 
inducing host cell apoptosis (Dasti, et al., 2010).  
Human infection 
Human Campylobacter infection is one of the most frequent causes of gastroenteritis in 
the United States and the world (Blaser, et al., 1983; WHO, 2012). It is more commonly reported 
in children, those immunocompromised and elderly people (Allos, 2001; Corry and Atabay, 
2001).  Infection is regarded as a foodborne disease rather than food poisoning and the majority 
of infections are sporadic (Griffiths and Park, 1990; Friedman, et al., 2004). Thermophilic 
Campylobacters namely C. jejuni, C. coli, C. lari, and C. upsaliensis are responsible for 
campylobacteriosis (Thomas, et al., 1998). However, C. jejuni is the most commonly reported 
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followed by C. coli, together contributing over 95% of the total infections globally (Park, 2002; 
EFSA/ECDC., 2013). Campylobacter coli is more sensitive to antibiotics used in selective media 
and less survivable in colder temperature which may lead to an underestimate of its incidence in 
comparison to C. jejuni (Griffiths and Park, 1990). Studies on infective dose of C. jejuni have 
determined a very low infective dose of 500-800 cells (Robinson, 1981; Black, et al., 1988). 
Campylobacter jejuni is known to cause self-limiting illnesses with initial symptoms usually 
seen 2-5 days after oral ingestion but sometimes extending up to 10 days and characterized by 
onset of diarrhea, abdominal cramps and preceded by fever (Skirrow, 1977; Butzler, 2004). It has 
been noted that symptoms begin with mild watery diarrhea which soon becomes bloody. Bloody 
diarrhea is regarded as inflammation due to invasive nature of C. jejuni leading to enteritis and 
colitis (Russell, et al., 1993; Blaser, 1997). However, extra intestinal manifestations like 
meningitis, osteomyelitis and neonatal sepsis have been reported, although rarely (Butzler, 
2004). Various complications such as reactive arthritis, Guillian-Barré syndrome, irritable bowel 
syndrome and inflammatory bowel disorder may occur as sequelae of Campylobacter infection 
(Gumpel, et al., 1981; Allos, 1997; Hannu, et al., 2002; Yuki, et al., 2004; Spiller and Garsed, 
2009). 
Guillian-Barré syndrome. Guillian-Barré syndrome (GBS) is a post-infectious auto-
immune mediated neuropathy with characteristic rapid progressive weakness, sensory loss and 
slow clinical recovery (van Koningsveld, et al., 2007). Campylobacter infection has been known 
to precede GBS and their association was reported as early as 1982 by Rhodes and Tattersfield 
(Rhodes and Tattersfield, 1982). Campylobacter jejuni is the most frequently observed 
antecedent infection in cases of GBS and symptoms usually noted 1-3 weeks after onset of 
Campylobacter enteritis (Butzler, 2004). It is the most serious complication of 
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campylobacteriosis and approximately 20% of the patients are admitted to the hospital in the 
intensive care unit for respiratory ventilation (WHO, 2012). Guillian-Barré syndrome is reported 
to occur in 1 out of every 1000 campylobacterosis cases (Allos, 1997). Serological studies have 
estimated that 20-40 % of GBS patients had C. jejuni infection before the onset of GBS (Mishu 
and Blaser, 1993). Guillian-Barré syndrome can occur at any age but occurs more frequently 
with increasing age and is slightly more common in males than females with a ratio of 1.25 
(Hadden and Gregson, 2001).  
Four subtypes of GBS are acute inflammatory demyelinating polyadiculoneuropathy 
(AIDP), acute motor axonal neuropathy (AMAN), acute motor and sensory axonal neuropathy 
(AMSAN), and Fisher’s syndrome. Antecedent of Campylobacter infection is detected more 
frequently in AMAN subtype (Kuwabara, 2004). Chemical characterization of C. jejuni 
lipopolysaccharides indicates the presence of sialic acid and further investigation by Yuki and 
associates (1993) revealed an identical structure between the terminal structure of 
oligosaccharide of C. jejuni Penner’s serotype 19 and terminal tetrasacchharide of GM1 
ganglioside, establishing a molecular mimicry between them (Moran, et al., 1991; Yuki, et al., 
1993; Yuki, et al., 2004). Following infection with Campylobacter, the immune system is 
suspected of producing anti-ganglioside-reactive antibodies that cause antibody-complement-
mediated demyelination and/or axonal damage resulting in symptoms of GBS (Nachamkin, 
2001).  
Recovery from GBS is variable and fatality rates ranges from 2 to 18%, usually resulting 
from cardiovascular autonomic complications, ventilator-associated pneumonia and pulmonary 
thromboembolism (Hadden and Gregson, 2001). Campylobacter jejuni is also found in 
association with Fisher’s syndrome. Infection with Campylobacter produces the antibodies 
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against the GQ1b ganglioside, which damages the ocular motor nerve (Hughes and Cornblath, 
2005). As a consequence, unique clinical signs like opthalmoplegia (paralysis of eye muscle), 
ataxia (lack of coordinated movement of muscle) and areflexia (absence of nerve reflexes) are 
commonly seen (Kuwabara, 2004).  
Reactive arthritis. Reactive arthritis, a spondyloarthropatic disorder, is characterized by 
inflammation of joints and tissues occurring after gastrointestinal or genitourinary infection 
(Ajene, et al., 2013). The association of reactive arthritis with C. jejuni was first reported by 
Berden in 1978 (Berden, et al., 1979). It develops within 2 weeks after Campylobacter related 
gastroenteritis in humans (Berden, et al., 1979). The incidence of reactive arthritis varies from 0 
to 16% with a mean of 0.9% in Campylobacter infections (Ajene, et al., 2013). However, it is 
difficult to get true incidence because of varied clinical severity and milder cases that go 
frequently unreported (Pope, et al., 2007). Even though the burden of campylobacteriosis is 
higher among children < 5years, estimates indicate lower incidence of reactive arthritis in that 
particular age group (Ajene, et al., 2013; CDC, 2014). The most commonly affected age group is 
young adults, and both sexes have an equal chance of acquiring this illness (Pope, et al., 2007). 
The proposed pathogenesis is that bacteria, following invasion of mucosa, persist in the 
epithelium associated lymph node, liver and spleen which then disseminate into the joints 
causing inflammation and are often supported by CD4
+ T-cells (Hill Gaston and Lillicrap, 2003).  
Irritable bowel syndrome. Irritable bowel syndrome (IBS) is a relapsing functional 
disorder characterized by abdominal pain or discomfort associated with defecation or change in 
bowel habits (Quigley, et al., 2009). This illness is characterized by 2 or more of the following; 
fever, vomiting, acute diarrhea, or a positive bacteria stool culture (Spiller, 2007). The 
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prevalence of IBS in North America and Europe ranges 10-15% (Quigley, et al., 2009). About 
10% of IBS cases are reported to be caused by Camplobacter spp (Spiller and Garsed, 2009). 
The mechanism by which IBS develops with Campylobacter infection is not fully understood. It 
may be due to the proteins secreted by the organisms which cause bowel disturbances (Thornley, 
et al., 2001).  
Inflammatory bowel disorder. Inflammatory bowel disorder (IBD) is a poorly 
understood chronic disorder of the intestine and includes ulcerative colitis and Crohn’s disease 
with an incidence of 2 to 4 per 100,000 population (Papadakis and Targan, 1999; Bernstein, 
2009). Campylobacter jejuni has also been associated with the inflammatory bowel disorder and 
has been isolated from 10% of the IBD cases (Gradel, et al., 2009; WHO, 2012). The suggested 
mechanism is that pathogenic bacteria like C. jejuni causes cellular damage, either by cytotoxic 
effect and/or by host cell invasion, which promotes translocation of commensal bacteria and 
activation of T-cells leading to inflammation (Kalischuk, et al., 2009).  
Treatment and economic burden 
Even though milder cases of campylobacteriosis do not need antibiotic treatment, in 
circumstances such as high fever, prolonged illness (>1 weeks), bloody diarrhea, infection in 
pregnancy, HIV and immunocompromised individuals require treatment (Allos and Blaser, 1995; 
Allos, 2001). At one time, fluoroquinolones, specifically ciprofloxacin was used as the drug of 
choice (Allos and Blaser, 1995). The consequence of this therapy resulted in increased 
fluoroquinolone resistant Campylobacter strains in many parts of the world (Gaunt and Piddock, 
1996; Allos, 2001). The first report for the United States showed an increase of quinolone 
resistant Campylobacter isolates from 1.3 to 10.2% during the years 1992-1998 (Smith, et al., 
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1999). Another study from 2002 to 2007 determined an increase from 15.2 to 17.2% of 
ciprofloxacin resistant C. jejuni in the United States (Zhao, et al., 2010). Presently, erythromycin 
is becoming popular as the treatment of choice due to its low toxicity, narrow spectrum activity, 
and low cost (Allos and Blaser, 1995). However, overall cost for treatment of campylobacteriosis 
is often expensive. In the United States, estimates have shown an approximate cost of $1846 per 
treatment for each case of campylobacteriosis with a total economic burden of approximately 
$1.7 billion per annum (Hoffmann, et al., 2012; Scharff, 2012). Similarly, the cost of illness per 
case in New Zealand was $600, in total contributing 90% of the total cost ($86million) of 
foodborne illness (Lake, et al., 2010). A report from European Union estimated an economic loss 
of €2.4 billion from campylobacteriosis (EFSA Panel on Biological Hazards, 2011). These 
burden studies highlight the need of control measures through multistep intervention to reduce 
the load of Campylobacter on the farm as well as in the processing facility (WHO, 2012).  
CAMPYLOBACTER IN POULTRY 
Incidence in poultry 
Campylobacter is widely present in poultry worldwide. Studies have reported 
Campylobacter incidence up to 90% of poultry flocks in the United States (Stern, et al., 2001), 
47.5% in Japan (Haruna, et al., 2012), 41.1% in Germany (Atanassova and Ring, 1999), 50% in 
organic chickens in Quebec (Thibodeau, et al., 2011) and more than 90% in Great Britain (Evans 
and Sayers, 2000). The incidence in European countries varies from 2% to 100% with an average 
of 71.2% in broiler flocks (EFSA, 2010). Higher incidences were reported from Luxemberg 
(100%), Malta (96.8%) and Spain (88%) (EFSA, 2010). The incidence of Campylobacter in 
poultry meat and its products is variable. One study determined 70.7% of broiler carcasses in 
supermarkets were contaminated in Washington, D.C. (Zhao, et al., 2001). Rates of 
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Campylobacter in broiler carcasses were 45.9% in Germany (Atanassova and Ring, 1999), 
93.2% in Australia (Pointon, et al., 2008), 64.7% in Japan (Sallam, 2007), 59.3% in Iran 
(Zendehbad, et al., 2013), 20.8% in Estonia (Mäesaar, et al., 2014), 84.3% in the Republic of 
Ireland (Madden, et al., 2011) and 91% in Northern Ireland, Scotland, England and Wales 
(Moran, et al., 2009). Overall EU prevalence of Campylobacter in broiler meat is 75.8 % (EFSA, 
2010). This variability in prevalence of Campylobacter in poultry flocks and carcasses is due to 
factors like differences in sampling collection, detection methodology, geographical location, 
season and production practices (Lee and Newell, 2006). Campylobacter counts in retail poultry 
meat range from 3 to 7 Log CFU/chicken (Jørgensen, et al., 2002; Manfreda, et al., 2006; Klein, 
et al., 2007) and C. jejuni is the dominant Campylobacter species most frequently isolated from 
retail poultry meat (Suzuki and Yamamoto, 2009).  
Mechanism of colonization in birds 
Campylobacter is naturally present in the gastrointestinal tract of poultry, more precisely 
in the ceca, larger intestine and cloaca (Beery, et al., 1988; Achen, et al., 1998). Most studies 
report that Campylobacter is a commensal bacterium in chickens (Beery, et al., 1988; Stern, et 
al., 1988; Dhillon, et al., 2006; Knudsen, et al., 2006; Smith, et al., 2008; Van Deun, et al., 
2008b; Shaughnessy, et al., 2009). However, a few studies have noted a condition of vibrionic 
hepatitis and some clinical signs like diarrhea and mortality in chicks (Lam, et al., 1992; Corry 
and Atabay, 2001). Campylobacter rapidly colonizes the ceca even with a very low dose (<50 
CFU) in day of hatch chicks reaching a very high concentration in the ceca up to 106-108CFU/g 
at the time of slaughter (Stern, et al., 1988; Stern, et al., 1995; Achen, et al., 1998; Knudsen, et 
al., 2006). Colonization is favored by the avian body temperature which is close to the optimum 
growth requirement (42°C) of thermophilic Campylobacters (Mead, 2002). The mechanism 
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behind colonization, although not fully understood, is believed to involve a dynamic process of 
adherence, invasion, escape from cell layers, fast replication in mucus and re-invasion which 
enables the bacteria to persist in the gut despite the intestinal clearance (Van Deun, et al., 2008b). 
Furthermore, modulation of immune response and down-regulation of expression of 
antimicrobial peptide genes may aid in the persistent high levels of Campylobacter in poultry 
(Meade, et al., 2009).  Even though Campylobacter preferentially resides in the cecal crypts 
utilizing mucin as an energy source (Beery, et al., 1988; Hugdahl, et al., 1988), studies have 
reported ability to invade the liver, spleen, heart and lungs (Young, et al., 1999; Knudsen, et al., 
2006; Meade, et al., 2009). 
Transmission 
Horizontal transmission. Poultry initially gets colonized with Campylobacters from 
environment sources such as rodents, livestock, wild birds, flies or water and birds are usually 
colonized by 2-3 weeks of age (Kapperud, et al., 1993; Corry and Atabay, 2001; van Gerwe, et 
al., 2009). Fecal shedding starts immediately after colonization leading to contamination of 
water, feed, and litter (Mead, 2002). Coprophagic behavior of chickens and communal source 
drinking water are mainly responsible for the rapid transmission throughout the flock (Keener, et 
al., 2004). As dry conditions of feed don’t favor the survival of bacterium, feed has not been 
linked as a source of transmission (Newell and Fearnley, 2003). It is estimated that 2.37 new 
birds get colonized for every single colonized bird per day (van Gerwe, et al., 2009).  
Vertical transmission. The role of vertical transmission of Campylobacter from poultry 
hen to chicks is still debatable.  Various studies, however, have noted Campylobacter in the 
reproductive tracts of male and female birds, and possibly that could play a role in vertical 
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transmission (Pearson, et al., 1996; Buhr, et al., 2002; Cox, et al., 2002a; Cox, et al., 2002b; 
Donoghue, et al., 2004; Cox, et al., 2005). Experimental studies had reported that C. jejuni does 
not easily penetrate the egg shell and even if it does contaminate the egg content, would not 
likely survive for more than 48 h when stored at room temperature (25°C) (Doyle, 1984; 
Shanker, et al., 1986). One study has indicated the presence of inoculated C. jejuni in egg yolks 
up to 14 days when eggs are stored at 18°C, however, Campylobacter was not isolated from the 
eggs of broiler breeder obtained from Campylobacter positive commercial hatchery (Sahin, et 
al., 2003a). There is also a lack of evidence of Campylobacter in 60,000 progeny of parent 
breeder birds hatched from eggs of positive tested grandparent flocks (Callicott, et al., 2006). 
Therefore, it appears that vertical transmission either doesn’t occur or occurs only rarely in 
chickens (Doyle, 1984; Shanker, et al., 1986; van de Giessen, et al., 1992; Jacobs-Reitsma, et al., 
1995; Sahin, et al., 2003a; Callicott, et al., 2006).  
PREVENTION STRATEGIES 
Research on prevention of Campylobacter at the farm level and on the processing plant is 
becoming important with the rising occurrence of campylobacteriosis.  Reductions in 
Campylobacter counts in pre or post-harvest poultry could significantly benefit human health as 
suggested by Rosenquist and co-workers (2003).  They did a risk assessment and reported a 
potential 30 fold reduction in the human incidence of campylobacteriosis with a 2 Log reduction 
of Campylobacter counts on broiler carcasses. The European Food Safety Authority’s risk 
assessment concluded that a 3 Log reduction in enteric Campylobacter counts or a 2 Log 
reduction on carcasses would reduce the risk of campylobacteriosis by at least 90% (EFSA Panel 
on Biological Hazards, 2011). These studies underscore the importance of control strategies at 
the farm and at the post-harvest facilities.  
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Pre-harvest prevention strategies 
Pre-harvest prevention strategies include implementation of biosecurity measures to limit 
bird’s exposure to the environment (Giessen, et al., 1998; Gibbens, et al., 2001; Fraser, et al., 
2010; Newell, et al., 2011) and utilization of bacteriophage (Loc Carrillo, et al., 2005; Wagenaar, 
et al., 2005), bacteriocins (Stern, et al., 2005; Svetoch and Stern, 2010), probiotics (Morishita, et 
al., 1997), vaccines (Widders, et al., 1996; Buckley, et al., 2010), and feed or water 
supplementation of natural compounds (de Los Santos, et al., 2010; Molatová, et al., 2011) to 
reduce or prevent colonization in birds.  
Biosecurity. Implementation of biosecurity measures such as cleaning and disinfection 
procedures, control of rodents, changing of footwear and washing hands before entering the 
farms have significant impact on reduction of Campylobacter prevalence in flocks (Hermans, et 
al., 2011b). A study conducted on Dutch broiler farms reported reduction of Campylobacter 
positive flocks from 66% to 22% on one farm and from 100% to 42% on a second farm 
(Giessen, et al., 1998). The application of standard methods of cleaning and disinfection, and 
hygiene protocols for all personnel entering the facility has shown a reduction in the prevalence 
in broiler flocks from 80 to <40% in the United Kingdom (Gibbens, et al., 2001).  However, 
studies have reported that such interventions only delay the colonization and doesn’t guarantee 
the complete elimination from flocks (Wagenaar, et al., 2006; Vandeplas, et al., 2008). 
Campylobacters are ubiquitous in the environment and hygienic measures should be 
implemented consistently, which is difficult to maintain (Newell, et al., 2011). Additionally, cost 
associated with those measures and farmer reluctance for adoption further limits the feasibility of 
biosecurity (Fraser, et al., 2010).  
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Bacteriophage. Bacteriophages are viruses, an obligate intracellular parasite lacking their 
own metabolism, capable of infecting and killing bacteria (Hagens and Loessner, 2007). There 
are two types of phage, virulent and temperate, the virulent types being able to infect and 
replicate in the genome, subsequently killing the host, are of particular importance for 
eradication of pathogens (Huff, et al., 2005). Phages are extremely host specific and 
Campylobacter specific phages have been isolated from multiple source including human, pig 
and poultry excreta, abattoir effluent, sewage and poultry meat (Salama, et al., 1989; Atterbury, 
et al., 2003b; Connerton, et al., 2004). Atterbury and colleagues (2005) reported a negative 
correlation between the presence of bacteriophage in ceca and Campylobacter counts.  When 
chickens were dosed with phage, the amount of Campylobacter reduction was variable based on 
treatment dose, phage type, application methods, and time elapsed after administration (Loc 
Carrillo, et al., 2005). A significant reduction by 2 Log CFU/g in cecal Campylobacter counts 
has been reported in two studies (El-Shibiny, et al., 2009; Carvalho, et al., 2010). In a separate 
study, Loc Carrillo and associates (2005) determined a reduction of Campylobacter counts of 0.5 
to 5 Log following phage treatment.  Wagenaar and co-workers (2005) reported that 
bacteriophage treatment only delayed colonization for a week, thus proposing that poultry should 
only be treated a few day before slaughter (Wagenaar, et al., 2005). Research have shown that it 
is possible to reduce Campylobacter counts on chicken skin with phage application (Atterbury, et 
al., 2003a; Goode, et al., 2003).  Although phage treatment has had no reported adverse effects 
on human health (Hagens and Loessner, 2010), the potential development of phage resistant 
Campylobacter, as seen in some of the studies (El-Shibiny, et al., 2009; Carvalho, et al., 2010) 
and consumer acceptance of poultry coated with viruses may limit its use in poultry (Janež and 
Loc-Carrillo, 2013).    
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Bacteriocins. The antimicrobial proteins or peptides produced by bacteria that either kill 
or inhibit the growth of other bacteria are termed bacteriocins (Cleveland, et al., 2001). 
Bacteriocins are often considered natural and safe as there are no known toxic effects and act by 
creating pores in the target cell membrane (Cleveland, 2001; Joerger, 2003). These are produced 
by both gram positive and gram negative bacteria commonly belonging to the genera of 
Lactobacillus, Lactococcus, Pediococcus, Carnobacterium, Enterococcus, Escherichia, Bacillus, 
Paenibacillus, Staphylococcus, Pseudomonas, and Clostridium (Svetoch and Stern, 2010). 
Bacteriocins, B602, OR7, E760, and E50-52 produced respectively by Paenibacillus polymyxa, 
Lactobacillus salivarius, Enterococcus durans/faecium/hirae and E. faecium have been widely 
studied against Campylobacter in poultry (Stern, et al., 2005; Stern, et al., 2006; Line, et al., 
2008; Svetoch, et al., 2008). All of these bacteriocins reduce Campylobacter with very high 
reduction in broiler and turkey poults (Stern, et al., 2005; Cole, et al., 2006; Stern, et al., 2006; 
Line, et al., 2008; Svetoch, et al., 2008). Studied on supplementation of E706 in drinking water 
of experimentally and naturally infected broilers resulted in complete elimination of bacteria in 
90% of the cases; the most effective treatment reported with bacteriocin (Svetoch and Stern, 
2010).  However, bacteriocins require microencapsulation to protect them from proteolytic 
activity of host proteases, which increases the cost of these compounds (Joerger, 2003; Svetoch, 
et al., 2005). Although a low level of resistance of Campylobacter to bacteriocin has been 
reported both in laboratory and in vivo studies using a single strain, natural transformation of 
acquired resistance genes among the Campylobacter strains could potentially reduce the efficacy 
of these substances (Hoang, et al., 2011a; Hoang, et al., 2011b). Moreover, use of bacteriocins 
requires regulatory approval by the U.S. Food and Drug Administration (FDA) and presently 
nisin is the only approved bacteriocin in the United States (Joerger, 2003). Unfortunately, it has 
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been reported that nisin is ineffective against C. jejuni in chicken meat juice (Piskernik, et al., 
2011).   
Probiotics and competitive exclusion. Probiotics are live microorganisms, which confer 
beneficial effects on the host by enhancing the gut microflora (Fuller, 1989). The exact 
mechanism by which probiotics work in the gut is still not known. However, it is proposed that 
probiotics have several actions including production of bacteriocins, competition for nutrients, 
stimulation of systemic immune response, and adhering and occupying space which enables the 
beneficial organisms to competitively eliminate pathogens from the gut (Fooks and Gibson, 
2002). Microorganisms that have been used as probiotics belong to certain bacterial species, 
Lactobacillus, Bifidobacterium, Lactococcus, Streptococcus, Enterococcus, E. coli, Bacillus and 
a variety of yeast species (Patterson and Burkholder, 2003). Prebiotics, the non-digestible 
substances that selectively supports the growth of beneficial bacteria, are used in combination 
with probiotics called synbiotics to enhance their efficacy (Gibson and Roberfroid, 1995; 
Patterson and Burkholder, 2003). One application of probiotics is that they are used as 
competitive exclusion (CE) cultures to eliminate or reduce pathogens from the poultry gut; a 
principal developed based on Nurmi and Ratala’s research on Salmonella (Nurmi and Rantala, 
1973). Competitive exclusion cultures have the ability to reduce Salmonella counts in poultry, 
however, inconsistent results have been reported against Campylobacter (Newell and Wagenaar, 
2000; Humphrey, et al., 2007).  Research on combination treatments in our laboratory also 
demonstrated the potential of some probiotic isolates to reduce enteric Campylobacters with 
mannanoligosaccharide supplementation but not with fructoligosaccharide in poultry (Arsi, 
2014). The difficulty in development of CE cultures against Campylobacter is possibly due to the 
unique ecological niche that it occupies in the ceca of poultry (Newell and Wagenaar, 2000).  
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Vaccination. Vaccination has been a widely used method for the prevention of major 
poultry diseases on a commercial scale. Despite the extensive research on vaccine development 
against Campylobacter, an effective vaccine has yet to be developed commercially (Jagusztyn-
Krynicka, et al., 2009). Evidence suggests that early protection of young chicks from 
colonization of Campylobacter is linked with the Campylobacter specific maternal antibodies 
(Sahin, et al., 2003b). Several researchers have reported an increase in serum IgG or mucosal 
IgA or both following immunization with different types of vaccine candidates leading to 
protection to some extent (Widders, et al., 1996; Rice, et al., 1997; Wyszyńska, et al., 2004; 
Buckley, et al., 2010; Huang, et al., 2010; Annamalai, et al., 2013). Studies mainly focus on two 
types of vaccines, killed whole-cell and subunits vaccine, the latter comprising immunodominant 
Campylobacter proteins including, but not limited to, flagellin, OMP (outer membrane protein), 
CjaA, CjaC, and CjaD based vaccines (de Zoete, et al., 2007). The more promising results were 
determined with CjaA and CjaD based subunit vaccine as they elicit better humoral response 
with higher serum IgG and secretory IgA (Wyszyńska, et al., 2004; Layton, et al., 2011). In one 
study, oral immunization (at day 1 and in the 2nd week) with avirulent Salmonella vaccine 
carrying C. jejuni cjaA gene reduced colonization by at least 6 Log CFU/g in birds challenged at 
4 weeks age (Wyszyńska, et al., 2004). In another study, administration of live Salmonella 
vectors expressing proteins of Cj0113 (omp18/CjaD) eliminated detectable Campylobacter on 
day 32 when birds were orally immunized on day of hatch and challenged with Campylobacter 
on day 21 (Layton, et al., 2011).  
Medium chain fatty acids. Medium chain fatty acids have demonstrated antimicrobial 
action against different microorganisms (Bergsson, et al., 1998; Van Immerseel, et al., 2004). 
Caprylic acid is one of the widely studied medium chain fatty acids and is classified as generally 
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recognized as safe (GRAS) category by U.S. FDA (Solis de los Santos, et al., 2008b). Previous 
research conducted in our laboratory showed that prophylactic and therapeutic supplementation 
of caprylic acid in feed significantly reduced Campylobacter by 3-4 Log CFU/g in both 10-day 
of age and market age broiler chickens (Solis de los Santos, et al., 2008a; Solis de los Santos, et 
al., 2008b; Solis de los Santos, et al., 2009; Solís de Los Santos, et al., 2010). In a separate study, 
feeding of birds with encapsulated fatty acids (caprylic and capric acid in a ratio of 1:1) 
throughout the rearing period (42 days) consistently reduced the fecal C. jejuni counts 
(Molatová, et al., 2011).  However, water supplementation of sodium salt of caprylic acids has 
produced inconsistent results against Campylobacter in chicken (Metcalf, et al., 2011). Despite 
the marked antimicrobial action in laboratory studies, Hermans and coworkers (2010) reported 
inefficacy of medium chain fatty acids when used as feed additives in birds. Hermans and 
coworkers (2010) suggested formulation of caprylic acid in the diet, differences in 
Campylobacter strains and bird’s genetics as factors responsible for contradictory results. Similar 
negative results were demonstrated in vivo study with butyrate; one of the most bactericidal short 
chain fatty acids against Campylobacter in laboratory tests (Van Deun, et al., 2008a). The 
marked discrepancy in results between in vivo and in vitro studies may be due to the protective 
effect of mucus in the cecal crypts where Campylobacter resides (Van Deun, et al., 2008a; 
Hermans, et al., 2010). 
Plant extracts. The use of plant products is increasing due to the restrictions on use of 
antibiotics in livestock and poultry production and shifting consumer preferences towards 
naturally occurring compounds (Burt, 2004; European Commission, 2005). Several compounds 
from plants including, but not limited to, phenols, quinones, flavones, tannins, coumarins, 
terpenoids, essential oils, alkaloids, and lectins possess antimicrobial properties against different 
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microorganism (Cowan, 1999). Various studies have been conducted using plant compounds to 
control Campylobacter in both pre-harvest and post-harvest poultry. In vitro studies have 
demonstrated antibacterial action of essential oils, such as trans-cinnamaldehyde, eugenol, 
carvacrol, and thymol against C. jejuni in cecal contents (Johny, et al., 2010a). However, these 
compounds fail to demonstrate a consistent reduction in cecal Campylobacters counts in chicken 
studies (Metcalf, 2008; Hermans, et al., 2011a; Arsi, et al., 2014). Earlier research in our 
laboratory showed at least a 5 Log reduction in Campylobacter counts with 2% or 4% cranberry 
extract in vitro, however, neither dose was able to reduce Campylobacter in the bird trial (Woo-
Ming, 2012). One experiment has determined antimicrobial activity of 9 out of 28 different fruit 
extracts with plum, lime and orange peel showing the greatest efficacy against Campylobacter 
(Valtierra-Rodríguez, et al., 2010). When mixtures of plum, lime and orange peel were applied to 
chicken skin inoculated with C. jejuni (105 CFU/mL) and incubated for 48 h at 4°C, it completely 
eliminated detectable Campylobacter (Valtierra-Rodríguez, et al., 2010). The combination of 
rosemary extract and pre-freezing (-20°C for 24 h) has shown synergistic effect reducing 
Campylobacter counts by  greater than 2 or 3 Log in chicken meat or juice, respectively 
(Piskernik, et al., 2011). Another study has reported the action of several other essential oils 
including marigold, ginger root, jasmine, carrot seed, celery seed, mugwort, patchouli, gardenia, 
spikenard, and cedarwood against C. jejuni (Friedman, et al., 2002). Research has also 
determined the antibacterial response of different types of tea, lemon, turmeric, and Chinese leek 
against Campylobacter (Lee, et al., 2004; Murali, et al., 2012). Further in depth research is still 
warranted to figure out the right dose and application method in commercial conditions. 
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Post-harvest prevention strategies   
Campylobacter contamination is a serious problem in processing plants and this 
contamination differs in various steps in processing including scalding, de-feathering, 
evisceration, and chilling.  A study determined the prevalence of Campylobacter contamination 
in the plant of 53.3%, 66.7%, 40% and 33.3% in carcasses after scalding and defeathering, 
evisceration, cooling and in finished breast meat with skin respectively (Klein, et al., 2007). 
Because of this occurrence of contamination, appropriate post-harvest strategies are necessary to 
control Campylobacter prevalence in retail poultry products. Post-harvest interventions are 
divided broadly into physical and chemical decontamination methods. Physical methods are 
comprised of steam, water, electrolyzed water, pressurized water, ozonated water, irradiation, 
ultrasound, air chilling and freezing (Loretz, et al., 2010). It has been reported that steam, hot 
water and electrolyzed water reduced Campylobacter 2.3-3.8, 0.9-2.1 or 1.1-2.3 Log, 
respectively in processed poultry (Loretz, et al., 2010). But these treatments can adversely effect 
carcass organoleptic properties (Dawson, et al., 1963; Cox, et al., 1974; Notermans and 
Kampelmacher, 1974; McMeekin and Thomas, 1978; Thomas and McMeekin, 1982; Whyte, et 
al., 2003). Boysen and Rosenquist (2009) revealed the effectiveness of freezing over air chilling, 
crust-freezing and steam-ultrasound. Even though a reduction in counts was obtained with 
freezing (-20°C), Campylobacters were recovered from the frozen sample and still present a risk 
for campylobacteriosis (Bhaduri and Cottrell, 2004). It was estimated that short term freezing (-
30°C) of chicken wings for 72 h reduces Campylobacter by 1.8 Log CFU/g, however, the 
condition used in poultry processing to superchill carcass to nonfrozen-state are not likely to 
reduce the counts significantly (Zhao, et al., 2003). 
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Chemical decontamination includes organic acids and chlorine based treatments. Reidel 
and coworkers (2009) have evaluated efficacy of 11 chemicals to reduce Campylobacter on 
chicken skin. When chicken skin was dipped for 1 min, they found the most effective treatment 
with cetylpyridinium chloride (0.5%) and benzalkonium chloride (1%) resulting in at least 4.2 
Log CFU/mL reduction in counts.  Formic acid (2%), lactic acid (2.5%), trisodium phosphate 
(10%), capric acid sodium salt (5%), and grapefruit seed extract (1.6%) also reduced 
Campylobacter in a range from 1.75 to 3.8 Log CFU/mL (Riedel, et al., 2009). Comparable 
reductions (2-2.7 Log CFU/mL) were determined when chicken legs were dipped for 1 min in 
20mM monocaprin (0.5%) (Thormar, et al., 2011). In a separate study, use of a combination of 
peracetic acid and hydrogen peroxide (85ppm) in poultry chillers decreases the Campylobacter 
positive carcasses by 43 % (Bauermeister, et al., 2008). However, studies have reported 
discoloration of skin when breast skin is dipped in different organic acids like acetic acid, citric 
acid, lactic acid, malic acid, mandelic acid and tartaric acid (Bilgili, et al., 1998). Residues in 
meat, problem in disposing of chemicals and their high costs are other problems associated with 
chemical treatments (SCVPH, 1998; EFSA BIOHAZ Panel, 2014). It should be taken into 
account that chemicals should be approved, have well documented efficacy, level and contact 
time suitable to use in processing plants, be cost-effective and should not produce any harmful 
effects on product quality to be applicable in industry (Bauermeister, et al., 2008).  
USE OF β-RESORCYLIC ACID IN PRE-HARVEST AND POST-HARVEST POULTRY 
B eta- resorcylic acid (BR) is a phenolic compound and as a secondary metabolite plays 
a crucial role in biochemistry and physiology of several plant species (Friedman, et al., 2003). 
This compound is used in foods as a flavoring substance (European Food Safety Authority, Ref 
no. 00910) and classified under the category of “Everything Added to Food in the United States” 
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by the US Food and Drug Administration (EAF 3045, CAS RN 89-86-1). Commercially, it is 
available in powder form as 2-4, dihydroxybenzoic acid (CAS: 89-86-1, Sigma-Aldrich Co., 
MO, USA). Beta-resorcylic acid is soluble in hot water, alcohol, ether and olive oil and boiling 
often results in loss of CO2 (O'Neil, et al., 2001).  
Mechanism of action 
The exact mechanism by which BR kills or inhibits the growth of microorganisms is not 
well known and knowledge regarding antimicrobial action is limited by lack of specific research 
related to this compound. However, being a weak acid, like benzoic acids, it is thought to act in 
an undissociated form which diffuses passively through bacterial cell membranes and causes a 
pH imbalance leading to disruption of biochemical processes and uncoupling of cellular energy 
production (Friedman, et al., 2003; Baskaran, et al., 2013b).  
Research on β -resorcylic acid  
Early research in the 1950s evaluated BR for its antimalarial activity against Plasmodium 
lophurae in Leghorn chicks (Thompson, et al., 1953). When this compound was administered 
with salicylic acid in rats infected with Trypansosoma lewisi, it reversed the activity of salicylic 
acid resulting in reduction of Trypansosoma population in blood but did not exhibit any 
antiablastic activity itself (Becker, 1961). Further study has demonstrated the antibacterial 
activity of BR against C. jejuni, in vitro (Friedman, et al., 2003). In a recent study, it was 
determined that BR increased the sensitivity of Salmonella Typhumurium H3380 to ampicillin, 
chloramphenicol, streptomycin, and sulfonamide (Johny, et al., 2010b). Mattson and colleagues 
(2011) reported concentration-dependent action of BR when tomatoes inoculated with 
Salmonella (108CFU) were dipped for 1 min in BR treatment solution. Salmonella was reduced 
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to less than 1.0 Log CFU/mL and 3.0 Log CFU/mL respectively by 1% and 0.75% BR after 1 
min exposure, however, both doses decreased this pathogen to undetectable levels at 3 min 
exposure without change in color (Mattson, et al., 2011). In another study, the same dose (1%) of 
BR, even at 1 min exposure, eliminated detectable counts of E. coli 0157:H7 when used for 
washing of infected apples (6.6 Log CFU/apple; Baskaran, et al., 2013b). Research on BR 
against E. coli 0157:H7 in decontamination of cattle hides has been shown to be more 
effectiveness by spraying of 1% BR solution on hides at 60°C than at 23°C (Baskaran, et al., 
2013a). This compound was also tested against Listeria monocytogenes in frankfurters. Dipping 
of frankfurter experimentally infected with L. monocytogenes (6 Log CFU/frankfurter) in 1.5% 
BR solution at 65°C for 30 s consistently reduced this bacterium during storage and eliminated 
detectable counts by the end of storage period on day 70 (Upadhyay, et al., 2013). 
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ABSTRACT 
Campylobacteriosis is one of the leading foodborne illnesses in United States, and is 
associated with the consumption of poultry and poultry products. Reducing Campylobacter in 
these species will reduce the burden of this disease. Unfortunately, most strategies employed to 
reduce Campylobacter in chicken have either not been successful or produced inconsistent 
results. One potential control strategy is the use of β-resorcylic acid (BR), a phytophenolic 
compound classified by the US FDA as “Everything Added to Food in the United States” (EAF 
3045) and is therefore deemed safe for consumption. This compounds has antibacterial activity 
against Salmonella, however, its efficacy to control Campylobacter in poultry has not been 
evaluated. Preliminary studies in our laboratory demonstrated that BR kills Campylobacter 
jejuni, in vitro. Therefore, the objective of this study was to evaluate whether BR would reduce 
Campylobacter in chickens. In pre-harvest studies, day of hatch chicks were fed one of five 
treatments (0, 0.25, 0.5, 1 or 2%BR) in the first trial, whereas a second trial was conducted 
including two additional doses of 0.75% & 1.5% BR (n=10 chicks/dose). Birds were challenged 
with mixture of four wild strains of C. jejuni (~ 106CFU/mL) on day 7 and cecal samples were 
collected on day 14 and enumerated for Campylobacter. In post-harvest studies four trials, two 
each on thigh skin and breast meat, were conducted. Chicken skin or meat samples (2±0.1g) 
were inoculated with 50µL of C. jejuni (~ 107 CFU/mL). Following 30 min of attachment, 
samples were dipped into their respective treatment solutions (0, 0.5, 1, 2% BR) for 30 s and 
suspended 2 min (n=10 samples/dose) and evaluated for reduction in Campylobacter counts. 
Data were analyzed by PROC GLM procedure of SAS (P < 0.05). Campylobacter counts were 
reduced by 1.4 Log CFU/g for the 2% dose in the first pre-harvest trial and by 4.2 or 2.8 Log 
CFU/g for the 0.5 % & 1% BR doses in the second pre-harvest trial.  In the post-harvest studies, 
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all doses of BR significantly reduced Campylobacter counts in both meat and skin. Results of 
these experiments suggest post-harvest application of BR is the most effective treatment and may 
help reduce the incidence of human campylobacteriosis. 
 
Key words: Campylobacter jejuni, β-resorcylic acid, pre-harvest, post-harvest, chicken. 
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INTRODUCTION 
Campylobacter contamination of food products is the leading causes of foodborne illness 
worldwide (Altekruse, et al., 1999; Hall, et al., 2005; WHO, 2012; CDC, 2014; EFSA, 2013). 
Campylobacter, in particular Campylobacter jejuni, is the second most commonly reported 
foodborne pathogen in the United States (Salmonella is the first) in causing an estimated 850,000 
illnesses and 13,256 quality-adjusted life year loss per year (Scallan, et al., 2011; Batz, et al., 
2014; CDC, 2014). Actual cases are probably higher than these estimates due to under-reporting 
or sick individuals not seeking medical attention (Skirrow, 1991; Mead, et al., 1999; Samuel, et 
al., 2004). Campylobacter has been reported to cause mild to severe gastro-enteritis and 
occasionally results in Guillain-Barré syndrome, reactive arthritis, or irritable bowel syndrome 
(Berden, et al., 1979; Rhodes and Tattersfield, 1982; Spiller, 2007; Gradel, et al., 2009). Studies 
have indicated that improper handling or consumption of chicken or other food products cross 
contaminated with poultry meat or juices during food preparation as a common cause of 
campylobacteriosis (Altekruse, et al., 1999; Rosenquist, et al., 2003; Friedman, et al., 2004a; 
Danis, et al., 2009; Lindmark, et al., 2009; Luber, 2009; Fajo-Pascual, et al., 2010).   
Campylobacter spp is normally colonized in the gastrointestinal tract of chickens by the 
third to fourth week of age and is a commensal organism in poultry (Annan-Prah and Janc, 1988; 
Stern, et al., 1988; Humphery, et al., 1993; Dhillon, et al., 2006; ). Various studies have reported 
enteric colonization up to 106-108 colony forming unit (CFU)/g of cecal material (Achen, et al., 
1998; Beery, et al., 1988) and concluded that high fecal contamination can occur during transport 
and during slaughter (Berrang, et al., 2000; Herman, et al., 2003; Reich, et al., 2008).  Up to  
90% of retail chicken carcasses have detectable Campylobacter contamination (Stern, et al., 
2001; Wong, et al., 2007) ranging from 3 to 7  Log CFU/per chicken (Jørgensen, et al., 2002; 
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Manfreda, et al., 2006; Klein, et al., 2007). As C. jejuni has a low infective dose of 
approximately 400 cells (Black, et al., 1988), poultry products present a high risk of 
Campylobacter infections in humans. Therefore, studies have emphasized the importance of 
controlling Campylobacter in poultry flocks at the farm level and on carcasses during processing 
in order to reduce the incidence of campylobacteriosis (Rosenquist, et al., 2003; Arsenault, et al., 
2007; Reich, et al., 2008). 
Current approaches for reduction of Campylobacter in poultry and poultry products 
include both pre- and post-harvest interventions. Different strategies have been tried to eliminate 
or reduce Campylobacter in pre-harvest poultry including; implementation of strict biosecurity to 
limit bird’s exposure to environmental sources (Giessen, et al., 1998; Gibbens, et al., 2001; 
Fraser, et al., 2010; Newell, et al., 2011) treating with bacteriophages (Loc Carrillo, et al., 2005; 
Wagenaar, et al., 2005) bacteriocins (Stern, et al., 2005; Svetoch and Stern, 2010) prebiotics 
(Morishita, et al., 1997; Arsi, 2014) vaccines (Widders, et al., 1996; Buckley, et al., 2010) or 
natural compounds (Solis de los Santos, et al., 2010; Molatová, et al., 2011; Woo-Ming, 2012; 
Arsi, et al., 2014). Unfortunately, most of these treatments have had limited success or produced 
inconsistent results.   
Researchers have also tried to reduce Campylobacter on broiler carcasses by physical and 
chemical methods in post-harvest poultry. Chemical interventions studied have included use of 
organic acids, chlorine or phosphate based treatments (Zhao and Doyle, 2006; Bauermeister, et 
al., 2008; Riedel, et al., 2009; Birk, et al., 2010; Thormar, et al., 2011).  Although these 
interventions yielded reductions in the range from 1 to 2.2 Log (Loretz, et al., 2010), acceptance 
has been limited due to residues or discoloration of meat, consumer preference for meat without 
additives, disposing of the hazardous waste and the high cost of treatment (Bilgili, et al., 1998; 
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SCVPH, 1998; EFSA BIOHAZ Panel, 2014). Physical methods like freezing, hot water or steam, 
electrolyzed water, irradiation, ultrasound, and air chilling have also been tested (Patterson, 
1995; Park, et al., 2002; Corry, et al., 2007; James, et al., 2007; Musavian, et al., 2014). Various 
studies have reported that hot water (>600C) or steam exert adverse effects on carcass appearance 
(Dawson, et al., 1963; Cox, et al., 1974; Whyte, et al., 2003). Immersion can cause swelling of 
skin and tissue allowing bacteria to move deeper into the tissue making their removal more 
difficult (Notermans and Kampelmacher, 1974; McMeekin and Thomas, 1978; Thomas and 
McMeekin, 1982) and Campylobacter survived even after freezing (Bhaduri and Cottrell, 2004).  
Furthermore, Boysen and colleagues (2013) have reported that reductions observed after 
inoculating carcasses with just one Campylobacter strain are not representative of carcasses 
naturally exposed to multiple Campylobacter species during production or in the processing 
plant.  Therefore, our post-harvest part of this studies was designed using four strains of C. jejuni 
and chicken skin and meat samples were inoculated to obtain a more representative 
contamination scenario.  
The use of plant antimicrobials has gained renewed attention with the restriction of 
antibiotics in livestock production worldwide (European Commission, 2005; Perkins, 2012). In 
this study, we evaluated the ability of the natural plant compound, β-resorcylic acid (CAS: 89-
86-1, Sigma-Aldrich Co., MO, USA) to reduce Campylobacter in both pre- and post-harvest 
poultry.  Beta-resorcylic acid (BR; 2, 4 dihydroxybenzoic acid) is a phytophenolic compound 
widely distributed among the angiosperms and is a secondary metabolite that plays a key role in 
the biochemistry and physiology of plants (Friedman, et al., 2003). This compound is used in 
food as a flavoring substance (European Food Safety Authority, Ref no. 00910) and classified 
under the category of “Everything Added to Food in the United States” by the US Food and 
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Drug Administration (EAF 3045, CAS RN 89-86-1).  In vitro antibacterial activity of BR has 
been reported for C. jejuni (Friedman, et al., 2003), Salmonella spp (Mattson, et al., 2011), E.coli 
(Friedman, et al., 2004b; Baskaran, et al., 2013a) and Staphylococcus aureus (Friedman, et al., 
2004b; Alves, et al., 2013).  However, this is the first study to our knowledge in which BR has 
been evaluated for its ability to reduce Campylobacter both in pre-harvest and post-harvest 
poultry. 
MATERIALS AND METHODS 
In vitro efficacy of β-resorcylic acid on Campylobacter 
An in vitro experiment was conducted to confirm the antibacterial activity of BR against 
C. jejuni in the presence of cecal material. C. jejuni was prepared as per the methods previously 
described in our laboratory (Woo-Ming, 2012; Arsi, et al., 2014). Briefly, 10mL glycerol stocks 
of four wild strains of C. jejuni were cultured into 5mL Campylobacter enrichment broth (CEB, 
International Diagnostics Group, Bury, Lancashire, UK) and incubated at 42°C under 
microaerophilic condition (85% N2, 10% CO2, 5%O2) for 48 h. Subcultures of each strain were 
made in 5mL CEB and again incubated at 42°C under microaerophilic condition for 24 h. A wet 
mount preparation was made to check motility and viability under the microscope and all strains 
were mixed in a tube and centrifuge at 3000rpm for 10 min at 21°C. Supernatant solutions was 
discarded and cells were resuspended with equal volume of Butterfield’s phosphate diluent 
(BPD). The C. jejuni suspension was inoculated into pooled and autoclaved cecal content in a 
tube to obtain ~ 2x107 CFU/mL. Different treatment solutions were prepared by dissolving 
appropriated quantities of BR in CEB to obtain final concentration of 20, 30, 40, 50, 60, 70, and 
75mM. CEB was used as control solution. Then, 100mL of cecal content inoculated with C. 
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jejuni and 900mL of respective treatment solutions were added in separated tubes and incubated 
at 42°C under microaerophilic condition for 0, 8, and 24 h. Triplicates of each samples were 
made and serially diluted (1:10) in BPD. Samples were then plated in Campy line agar (CLA; 
Line, 2001) and incubated at 42°C under microaerophilic condition. Campylobacter colonies 
were enumerated after 48 h. 
Pre-harvest efficacy of β-resorcylic acid supplemented in chicken feed 
Experimental Design. Day of hatch broiler chicks (Cobb500) were obtained from a local 
commercial hatchery. Birds were weighed individually, randomly allocated into different groups 
and placed on separate floor-pens with pine shavings. Two trials were conducted with five 
treatments groups (0, 0.25%, 0.5%, 1%, 2% BR) in the first trial (n=10 chicks/treatment) and two 
additional treatments (0.75%, 1.5% BR), based on result of trial 1 in an attempt to determine the 
optimal dose for this compound, with a total of seven treatments in the second trial (n=10 
chicks/treatment). Beta-resorcylic acid was mixed in feed and birds were fed ad libitum water 
and treated or untreated feeds throughout the 14 day study period. Feed consumption, initial and 
final body weights of individual birds were recorded during this study. 
Campylobacter challenge and enumeration. Birds were challenged via oral gavage with 
four wild strains of Campylobacter jejuni on day 7. The Campylobacter challenge in BPD 
solution was prepared by a method previously used in our laboratory and described above for our 
in vitro study (Woo-Ming, 2012; Arsi, et al., 2014).  To quantitate the dose given to each chick, 
the inoculum was serially diluted (1:10) and plated on CLA (Line, 2001) plates. The cultured 
plates were incubated at 420C for 48 h under microaerophilic conditions for quantification of 
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challenge dose. The challenge dose was approximately 106 CFU/mL for both trials and each bird 
was inoculated with 0.25mL of the challenge solution. 
A method previously described in our laboratory was used for cecal Campylobacter 
enumeration (Cole, et al., 2006). On day 14, ceca were collected aseptically in sterile sample 
bags and the cecal contents were serially diluted and each dilution was subsequently plated on 
CLA for enumeration of Campylobacter. Presumptive Campylobacter colonies were directly 
enumerated and confirmation were made with a latex agglutination test (SCIMEDX Co., NJ, 
USA). 
Post-harvest efficacy of β-resorcylic acid on chicken skin and meat samples  
Sample Preparation. For the post-harvest trials, chicken was purchased from local 
grocery store and 2 g samples of skin (from chicken thigh) and meat (from breast meat) were 
prepared aseptically and stored at -20°C. During each trial, the samples were thawed and 
randomly allocated to each treatment group.  
Experimental design. A total of four trials, two each on skin or meat, were conducted. 
This experiment consisted of four treatment groups (0, 0.5, 1, & 2% BR), each trial having ten 
skin or meat samples. The treatment solution was made in BPD at 420C for better solubility 
(Budavari, 1989). First, samples were thawed to room temperature and a 50µL (~ 107 CFU/mL) 
of a cocktail of four wild strains of Campylobacter jejuni were inoculated onto meat or skin 
samples. After inoculation, the samples were kept at room temperature for 30 min to adhere 
bacteria onto the samples. All samples for each treatment group were dipped simultaneously into 
500mL of respective BR treatment or control solution for 30 s and dripped dried for 2 min. Each 
individual sample was then immediately transferred to separate tube with 18 mL of BPD, 
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vortexed, and the suspension was serial diluted in BPD, plated on Campy line agar (Line, 2001), 
and incubated at 420 C for 48 h under microaerophilic conditions. Direct colony counts were 
recorded and converted into CFU/g of sample.  
STATISTICAL ANALYSIS 
The Campylobacter mean CFUs were logarithmic transformed (Log CFU/g) to maintain 
the homogeneity of variance (Byrd, et al., 2001). The data were analyzed by using PROC GLM 
procedure of SAS 9.3 (SAS Institute, 2010). The treatment means were partitioned by 
LSMEANS analysis and a probability of P<0.05 required for statistical significance. 
RESULTS 
In vitro efficacy of β-resorcylic acid on Campylobacter 
There were significant reductions (4.7, 3.6, 5.1, 6.1 Log CFU/g) of Campylobacter 
counts  in vitro study with cecal material at 0 h by 50, 60, 70, and 75mM concentrations of BR 
respectively. All the concentrations (20, 30, 40, 50, 60, 70, 75mM) of BR showed significant 
reductions by at least 4.6 Log CFU/g after 8 and 24 h compared to control (Figure 1). 
Pre-harvest efficacy of β-resorcylic acid supplemented in chicken feed  
In our pre-harvest studies, cecal Campylobacter counts were reduced by 1.4 Log CFU/g 
in birds fed with 2% dose of BR in the first trial and by 4.2 Log CFU/g or 2.8 Log CFU/g for the 
birds fed 0.5% or 1% BR doses in the second trial when compared to Campylobacter control 
birds (Table 1). Body weight gain was significantly reduced in the birds fed 0.5, 1 and 2% doses 
of BR in the first trial and by 2% BR in the second trial when compared to controls. Total feed 
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consumption was reduced for the 2% BR group in trial 1 and all treatment groups in trial 2 when 
compared with controls (Table 2).   
Post-harvest efficacy of β-resorcylic acid on chicken skin and meat samples 
In the post-harvest studies, Campylobacter counts on meat or skin were significantly 
reduced for all doses of BR tested compared to the control in all the trials (Figure 2 & 3). The 
greatest reduction on meat was for the 2% BR dose in trial 1 (3.1 Log CFU/g) and either 1% or 
2% in trial 2 (1.9 Log CFU/g) when compared with controls.  On the skin samples, all three 
concentration of BR tested produced comparable reductions (1-1.2 Log CFU/g) in trial 1 and the 
2% dose had the greatest reduction (2.1 Log CFU/g) in trial 2 when compared with controls.     
DISCUSSION 
In vitro testing demonstrated that BR is effective at reducing or eliminating detectable 
Campylobacter counts in liquid media containing cecal contents.  The higher doses of BR (50-
75mM) produced an immediate reduction in counts after dosing (0 h) and reduced counts for the 
20mM dose or eliminated detectable Campylobacter counts for all the other doses (30-75mM) at 
8 or 24 h, respectively. These results are consistent with that of Friedman and coworkers (2003) 
and they speculated this was due to a change in pH, which alters the electrochemical balance of 
bacterial cell facilitating cell death. 
In the first pre-harvest trial using 0.25, 0.5, 1.0 or 2.0 % BR in the feed, enteric 
Campylobacter counts were reduced for only the highest dose (2%) of BR when compared with 
positive Campylobacter controls.  In the second trial, the additional doses of 0.75 and 1.5% BR 
were added to the study in an attempt to determine the optimal dose for this compound.  In this 
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trial, however, only the 0.5 and 1% but not the 2% doses of BR reduced enteric Campylobacter 
counts.   
It is unclear why there wasn’t consistent efficacy when dosing with BR in this pre-harvest 
study.   It is possible that there is variability of absorption of BR in individual bird’s digestive 
tracts.  This could potentially produce different BR concentrations reaching the ceca and 
subsequently impacting its efficacy on cecal Campylobacter colonization.  There are few studies 
on the absorption, metabolism, and mechanism of BR.  Beta-resorylic acid has a moderate 
dissociation constant (pKa 3.30) similar to benzoic acid (pKa 4.20) and as a weak acid remain in 
a non-dissociated form in the stomach and intestine (Mattoo, 1959; Milne, 1965). Weak acids in 
non-dissociated form are easily absorbed in acidic medium (Milne, et al., 1958). These reports 
might support the differences in BR efficacy due to absorption in the G.I tract.  Moreover, in 
vitro studies on anaerobic metabolism of resorcylic acid by fermenting bacteria such as 
Clostridium spp. in a co-culture with Campylobacter spp. sequentially cleaved into non-aromatic 
compounds (Kluge, et al., 1990).  Birds have diverse gut microflora and Clostridium can be 
found in the small intestine of young chicks (Amit-Romach, et al., 2004; Apajalahti, et al., 2004). 
Thus, there is a chance of degrading this compound into different compounds which may or may 
not possess antibacterial properties.  One possible solution to these potential issues is 
encapsulating BR to prevent quick absorption or rapid metabolism by other microflora.  
It is also reported that domestic fowl excrete benzoic acid and other aromatic acids in 
conjugation with ornithine, a compound derived from dietary arginine (Nesheim and Garlich, 
1963). A study on supplementation of 0.2% benzoic acids in broiler chickens reported arginine 
deficiency related reduction in growth performance (Józefiak, et al., 2010). Thus, a similar 
situation in which absorbed BR may lead to deficiency of arginine and impair the broiler 
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performance as seen in 2% BR inclusion. Upadhayaya et al (2014) had also reported the 
decreased in body weight gain with 1% BR when used to reduce colonization of Salmonella 
Enteritidis in 21-day broiler chickens. Reduction of body weight gain, as also observed in the 
current study (Table 2), rules out the possibility of increasing the BR dose to possibly improve 
its efficacy against Campylobacter due a concomitant reduction in production performance.   
Another potential cause for this variability is differences in each individual bird’s 
microbiome, not only within each trial but between trials.  Although it would be possible to 
eliminate this variable by raising gnotobiotic birds in environmentally sterile isolators, 
unfortunately it is not economically feasible for poultry producers to raise birds under these 
conditions.  Therefore, any treatment developed for commercial poultry production has to be 
rugged enough to reduce Campylobacter counts in birds acquiring microbes from diverse 
environments.  Treatment variability is not limited to the current study.  Previous reports from 
our laboratory (Metcalf, et. al., 2011; Woo-Ming, 2012; Arambel, 2014; Arsi, et. al., 2014) and 
others researchers (Hakkinen and Schneitz, 1999; Hermans, et. al., 2010; Robyn, et. al., 2013) 
have also reported variable results when evaluating treatment against Campylobacter in pre-
harvest poultry. 
Beta-resorcylic acid treatment rapidly reduced Campylobacter counts on both skin and 
meat samples when tested a few minutes after application (Figures 2 and 3). The greatest 
reduction on meat was for with 2% dose in trial 1 (3.1 Log CFU/g) and either the 1 or 2% dose in 
trial 2 (1.9 Log CFU/g).  On the skin samples, all three doses reduced Campylobacter counts in 
trial 1 (1-1.2 Log CFU/g) but the 2% dose provide the greatest reduction in trial 2 (2.1 Log 
CFU/g). A reduction by BR on both skin and meat is important since both skin and meat can be 
highly contaminated with Campylobacter (Hansson, et al., 2015; Jørgensen, et al., 2002). 
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The reduction reported in this study are supported by other researcher evaluating post-
harvest BR treatments on foods.  Baskaran and co-workers (2013b) washed apples with 0.5 % 
(pH 1.40) and 1% (pH 1.40) BR and reported undetectable counts of E. coli O157:H7 after a 5 
min exposure.  Treatment with one percent BR was more effective against E. coli 0157:H7 in 
treatment of cattle hides at 600C (4 Log CFU/cm2) than at 230 C (3 Log CFU/cm2) with no 
significant difference between the 2 min and 5 min exposure time (Baskaran, et al., 2013a).  
Salmonella spp were significantly reduced on tomatoes washed with deionized water containing 
0.75 or 1% BR following a 1 min exposure time (Mattson, et al., 2011).  The reduction in 
Campylobacter counts reported in the current study are similar to the reduction (1.57-1.78 Log 
CFU/mL) reported with formic acid (2%), lactic acid (2.5%), trisodium phosphate (10%), and 
capric acid sodium salt (5%) but not as great as the use of cetylpyridinium chloride (0.5%) and 
benzalkonium chloride (1%) (>4.2 Log CFU/mL) (Riedel, et al., 2009).   
In conclusion, application of BR in pre-harvest poultry produced an inconsistent 
reduction in enteric Campylobacter colonization but post-harvest application produced a 
consistent redution on both skin and meat post-harvest samples.  Follow-up testing is needed to 
evaluate the effect of BR on spoilage bacteria and organoleptic properties.  However, the 
reduction of BR on post-harvest poultry samples supports the potential evaluation of BR as part 
of a  multi-faceted stregety to reduce the incidence of this important human foodborne pathogen.  
  
67 
 
REFERENCES 
Achen, M., T. Y. Morishita, and E. C. Ley. 1998. Shedding and colonization of Campylobacter 
jejuni in broilers from day-of-hatch to slaughter age. Avian Dis. 42:732-737.  
 
Altekruse, S. F., N. J. Stern, P. I. Fields, and D. L. Swerdlow. 1999. Campylobacter jejuni-an 
emerging foodborne pathogen. Emerg. Infect. Dis. 5:28-35. 
 
Alves, M. J., I. C. F. R. Ferreira, H. J. C. Froufe, R. M. V. Abreu, A. Martins, and M. Pintado. 
2013. Antimicrobial activity of phenolic compounds identified in wild mushrooms, SAR 
analysis and docking studies. J. Appl. Microbiol. 115:346-357.  
 
Amit-Romach, E., D. Sklan, and Z. Uni. 2004. Microflora ecology of the chicken intestine using 
16S Ribosomal DNA primers. Poult. Sci. 83:1093-1098.  
 
Annan-Prah, A., and M. Janc. 1988. The mode of spread of Campylobacter jejuni/coli to broiler 
flocks. J. Vet. Med. 35:11-18.  
 
Apajalahti, J., A. Kettunen, and H. Graham. 2004. Characteristics of the gastrointestinal 
microbial communities, with special reference to the chicken. World Poult. Sci. J. 
60:223-232.  
 
Arambel, H. R.  2014. Chitosan reduces enteric colonization of Campylobacter in young 
chickens, but not on post-harvest chicken skin samples. Master thesis. University of 
Arkansas. 
 
Arsenault, J., A. Letellier, S. Quessy, and M. Boulianne. 2007. Prevalence and risk factors for 
Salmonella and Campylobacter spp. carcass contamination in broiler chickens 
slaughtered in Quebec, Canada. J. Food Prot. 70:1820-1828.  
 
Arsi, K. 2014. The efficacy of probiotic bacterial isolates in reducing cecal Camylobacter 
colonization in broiler chickens. PhD dissertation. University of Arkansas, United States. 
 
Arsi, K., A. M. Donoghue, K. Venkitanarayanan, A. Kollanoor-Johny, A. C. Fanatico, P. J. Blore 
and D. J. Donoghue. 2014. The Efficacy of the Natural Plant Extracts, Thymol and 
Carvacrol against Campylobacter Colonization in Broiler Chickens. Journal of Food 
Safety (In press). 
 
Baskaran, S. A., V. Bhattaram, I. Upadhyaya, A. Upadhyay, A. Kollanoor-Johny, Schreiber, Jr., 
and K. Venkitanarayanan. 2013a. Inactivation of Escherichia coli O157: H7 on cattle 
hides by Caprylic acid and β-Resorcylic acid. J. Food Prot. 76:318-322.  
 
Baskaran, S. A., A. Upadhyay, A. Kollanoor‐Johny, I. Upadhyaya, S. Mooyottu, M. A. Roshni 
Amalaradjou, D. Schreiber, and K. Venkitanarayanan. 2013b. Efficacy of plant‐derived 
antimicrobials as antimicrobial wash treatments for reducing enterohemorrhagic 
Escherichia Coli O157: H7 on apples. J. Food Sci. 78:M1399-M1404.  
68 
 
Batz, M., S. Hoffmann, and J. G. Morris Jr. 2014. Disease-Outcome Trees, EQ-5D Scores, and 
Estimated Annual Losses of Quality-Adjusted Life Years (QALYs) for 14 Foodborne 
Pathogens in the United States. Foodborne Pathog. Dis. 11:395-402. 
 
Bauermeister, L. J., J. W. Bowers, J. C. Townsend, and S. R. McKee. 2008. Validating the 
efficacy of peracetic acid mixture as an antimicrobial in poultry chillers. J. Food Prot. 
71:1119-1122.  
 
Beery, J. T., M. B. Hugdahl, and M. P. Doyle. 1988. Colonization of gastrointestinal tracts of 
chicks by Campylobacter jejuni. Appl. Environ. Microbiol. 54:2365-2370.  
 
Berden, J., H. Muytjens, and L. Van de Putte. 1979. Reactive arthritis associated with 
Campylobacter jejuni enteritis. Br. Med. J. 1:380.  
 
Berrang, M. E., R. J. Buhr, and J. A. Cason. 2000. Campylobacter recovery from external and 
internal organs of commercial broiler carcass prior to scalding. Poult. Sci. 79:286-290.  
 
Bhaduri, S., and B. Cottrell. 2004. Survival of cold-stressed Campylobacter jejuni on ground 
chicken and chicken skin during frozen storage. Appl. Environ. Microbiol. 70:7103-7109.  
 
Bilgili, S., D. Conner, J. Pinion, and K. Tamblyn. 1998. Broiler skin color as affected by organic 
acids: Influence of concentration and method of application. Poult. Sci. 77:752-757.  
 
Birk, T., A. C. Grønlund, B. B. Christensen, S. Knøchel, K. Lohse, and H. Rosenquist. 2010. 
Effect of organic acids and marination ingredients on the survival of Campylobacter 
jejuni on meat. J. Food Prot. 73:258-265.  
 
Black, R. E., M. M. Levine, M. L. Clements, T. P. Hughes, and M. J. Blaser. 1988. Experimental 
Campylobacter jejuni infection in humans. J. Infect. Dis. 157:472-479.  
 
Boysen, L., N. S. Wechter, and H. Rosenquist. 2013. Effects of decontamination at varying 
contamination levels of Campylobacter jejuni on broiler meat. Poult. Sci. 92:1425-1429.  
 
Buckley, A. M., J. Wang, D. L. Hudson, A. J. Grant, M. A. Jones, D. J. Maskell, and M. P. 
Stevens. 2010. Evaluation of live-attenuated Salmonella vaccines expressing 
Campylobacter antigens for control of C. jejuni in poultry. Vaccine 28:1094-1105.  
 
Budavari, S., Marydele J. O'Neil, Ann Smith, Patricia, E. Heckelman. 1989. The Merck Index. 
11 ed. Merck & Co., Inc., Rahway, NJ, USA. 
 
Byrd, J. A., B. M. Hargis, D. J. Caldwell, R. H. Bailey, K. L. Herron, J. L. McReynolds, R. L. 
Brewer, R. C. Anderson, K. M. Bischoff, T. R. Callaway, and L. F. Kubena. 2001. Effect 
of lactic acid administration in the drinking water during preslaughter feed withdrawal on 
Salmonella and Campylobacter contamination of broilers. Poult. Sci. 80:278-283.  
 
69 
 
Centers for Disease Control and Prevention, CDC. 2014. Incidence and trends of infection with 
pathogens transmitted commonly through food-Foodborne disease active surveillance 
network, 10 U. S. Sites, 2006-2013. MMWR: Morbidity and Mortality Weekly Report 
63:328-332. 
 
Cole, K., M. B. Farnell, A. M. Donoghue, N. J. Stern, E. A. Svetoch, B. N. Eruslanov, L. I. 
Volodina, Y. N. Kovalev, V. V. Perelygin, E. V. Mitsevich, I. P. Mitsevich, V. P. 
Levchuk, V. D. Pokhilenko, V. N. Borzenkov, O. E. Svetoch, T. Y. Kudryavtseva, I. 
Reyes-Herrera, P. J. Blore, F. S. de los Santos, and D. J. Donoghue. 2006. Bacteriocins 
reduce Campylobacter colonization and alter gut morphology in turkey poults. Poult. Sci. 
85:1570-1575.  
 
Corry, J. E., S. J. James, G. Purnell, C. S. Barbedo-Pinto, Y. Chochois, M. Howell, and C. 
James. 2007. Surface pasteurisation of chicken carcasses using hot water. J. Food Eng. 
79:913-919.  
 
Cox, N., A. Mercuri, J. Thomson, and D. Gregory. 1974. Quality of broiler carcasses as affected 
by hot water treatments. Poult. Sci. 53:1566-1571.  
 
Danis, K., M. Di Renzi, W. O'Neill, B. Smyth, P. McKeown, B. Foley, V. Tohani, and M. 
Devine. 2009. Risk factors for sporadic Campylobacter infection: an all-Ireland case-
control study. Euro. Surveill. 14:19123.  
 
Dawson, L., R. Walker, M. Zabik, D. Bigbee, and W. Mallmann. 1963. Influence of surface 
pasteurization and chlortetracycline on bacterial incidence on fyers. Food Tech. 17:218.  
 
Dhillon, A. S., H. L. Shivaprasad, D. Schaberg, F. Wier, S. Weber, and D. Bandli. 2006. 
Campylobacter jejuni Infection in Broiler Chickens. Avian Dis. 50:55-58.  
 
EFSA 2013. Rise in human infections from Campylobacter and E. coli, whilst Salmonella cases 
continue to fall: EFSA and ECDC 2011 zoonoses report. Accessed 5/30, 2014 
 
EFSA BIOHAZ Panel. 2014. Scientific opinion on the evaluation of the safety and efficacy of 
peroxyacetic acid solutions for reduction of pathogens on poultry carcasses and meat. 
EFSA Journal 12.  
 
EFSA. Food Flavourings. Ref. no. 00910. Accessed on Apr. 2014. 
 
European Commission. 2005. Ban on antibiotics as growth promoters in animal feed enters into 
effect. Accessed May 2014. 
 
Fajo-Pascual, M., P. Godoy, M. Ferrero-Cancer, and K. Wymore. 2010. Case-control study of 
risk factors for sporadic Campylobacter infections in northeastern Spain. Eur. J. Public 
Health 20:443-448.  
 
70 
 
Farnell, M. B., A. M. Donoghue, K. Cole, I. Reyes-Herrera, P. J. Blore, and D. J. Donoghue. 
2005. Campylobacter susceptibility to ciprofloxacin and corresponding fluoroquinolone 
concentrations within the gastrointestinal tracts of chickens. J. Appl. Microbiol. 99:1043-
1050.  
 
Food And Drug Administration. Everything Added to Food in the United States. Accessed 
04/23/2013. 
 
Fraser, R. W., N. T. Williams, L. F. Powell, and A. J. C. Cook. 2010. Reducing Campylobacter 
and salmonella infection: two studies of the economic cost and attitude to adoption of on‐
farm biosecurity measures. Zoonoses Public Health 57:e109-e115.  
 
Friedman, C. R., R. M. Hoekstra, M. Samuel, R. Marcus, J. Bender, B. Shiferaw, S. Reddy, S. D. 
Ahuja, D. L. Helfrick, F. Hardnett, M. Carter, B. Anderson, R. V. Tauxe, and G. 
Emerging Infections Program FoodNet Working. 2004a. Risk factors for sporadic 
Campylobacter infection in the United States: A case-control study in FoodNet sites. 
Clin. Infect. Dis. 3:S285-296.  
 
Friedman, M., R. Buick, and C. T. Elliott. 2004b. Antibacterial activities of naturally occurring 
compounds against antibiotic-resistant Bacillus cereus vegetative cells and spores, 
Escherichia coli, and Staphylococcus aureus. J. Food Prot. 67:1774-1778.  
 
Friedman, M., P. R. Henika, and R. E. Mandrell. 2003. Antibacterial activities of phenolic 
benzaldehydes and benzoic acids against Campylobacter jejuni, Escherichia coli, Listeria 
monocytogenes, and Salmonella enterica. J. Food Prot. 66:1811-1821. 
 
Gibbens, J. C., S. J. S. Pascoe, S. J. Evans, R. H. Davies, and A. R. Sayers. 2001. A trial of 
biosecurity as a means to control Campylobacter infection of broiler chickens. Prev. Vet. 
Med. 48:85-99.  
 
Giessen, A. W. v. d., J. J. H. C. Tilburg, W. S. Ritmeester, and J. v. d. Plas. 1998. Reduction of 
Campylobacter infections in broiler flocks by application of hygiene measures. 
Epidemiol. Infect. 121:57-66.  
 
Gradel, K. O., H. L. Nielsen, H. C. Schønheyder, T. Ejlertsen, B. Kristensen, and H. Nielsen. 
2009. Increased short-and long-term risk of inflammatory bowel disease after Salmonella 
or Campylobacter gastroenteritis. Gastroenterology 137:495-501.  
 
Hakkinen, M. and C. Schneitz. 1999. Efficacy of a commercial competitive exclusion product 
against Campylobacter jejuni. Br. Poult. Sci. 40:619-621 
 
Hall, G., M. D. Kirk, N. Becker, J. E. Gregory, L. Unicomb, G. Millard, R. Stafford, K. Lalor, 
and O. W. Group. 2005. Estimating foodborne gastroenteritis, Australia. Emerg. Infect. 
Dis. 11:1257-1264.  
 
71 
 
Hansson, I., A. Nyman, E. Lahti, P. Gustafsson, E. Olsson Engvall. 2015. Associations between 
Campylobacter levels on chicken skin, underlying muscle, caecum, and packaged fillets. 
Food Microbiol. 48: 178-181. 
 
Herman, L., M. Heyndrickx, K. Grijspeerdt, D. Vandekerchove, I. Rollier, and L. De Zutter. 
2003. Routes for Campylobacter contamination of poultry meat: epidemiological study 
from hatchery to slaughterhouse. Epidemiol. Infect. 131:1169-1180.  
 
Hermans, D., A. Martel, K. Van Deun, M. Verlinden, F. Van Immerseel, A. Garmyn, W. 
Messens, M. Heyndrickx, F. Haesebrouck, and F. Pasmans. 2010. Intestinal mucus 
protects Campylobacter jejuni in the ceca of colonized broiler chickens against the 
bactericidal effects of medium-chain fatty acids. Poult. Sci. 89:1144-1155. 
 
Humphery, T. J., A. Henley, and D. G. Lanning. 1993. The colonization of broiler chickens with 
Campylobacter jejuni: some epidemiological investigations. Epidemiol. Infect. 110:601-
607.  
 
James, C., S. J. James, N. Hannay, G. Purnell, C. Barbedo-Pinto, H. Yaman, M. Araujo, M. L. 
Gonzalez, J. Calvo, and M. Howell. 2007. Decontamination of poultry carcasses using 
steam or hot water in combination with rapid cooling, chilling or freezing of carcass 
surfaces. Int. J. Food Microbiol. 114:195-203.  
 
Józefiak, D., S. Kaczmarek, and A. Rutkowski. 2010. The effects of benzoic acid 
supplementation on the performance of broiler chickens. J. Anim. Physiol. Anim. Nutr. 
94:29-34.  
 
Jørgensen, F., R. Bailey, S. Williams, P. Henderson, D. R. A. Wareing, F. J. Bolton, J. A. Frost, 
L. Ward, and T. J. Humphrey. 2002. Prevalence and numbers of Salmonella and 
Campylobacter spp. on raw, whole chickens in relation to sampling methods. Int. J. Food 
Microbiol. 76:151-164.  
 
Klein, G., F. Reich, L. Beckmann, and V. Atanassova. 2007. Quantification of thermophilic 
Campylobacter spp. in broilers during meat processing. Antonie van Leeuwenhoek 
92:267-273.  
 
Kluge, C., A. Tschech, and G. Fuchs. 1990. Anaerobic metabolism of resorcyclic acids (m-
dihydroxybenzoic acids) and resorcinol (1, 3-benzenediol) in a fermenting and in a 
denitrifying bacterium. Arch. Microbiol. 155:68-74.  
 
Lindmark, H., S. Boqvist, M. Ljungström, P. Ågren, B. Björkholm, and L. Engstrand. 2009. Risk 
Factors for Campylobacteriosis: an Epidemiological Surveillance Study of Patients and 
Retail Poultry. J. Clin. Microbiol. 47:2616-2619.  
 
Line, J. E. 2001. Development of a selective differential agar for isolation and enumeration of 
Campylobacter spp. J. Food Prot. 64:1711-1715.  
72 
 
Loc Carrillo, C., R. J. Atterbury, A. El-Shibiny, P. L. Connerton, E. Dillon, A. Scott, and I. F. 
Connerton. 2005. Bacteriophage therapy to reduce Campylobacter jejuni colonization of 
broiler chickens. Appl. Environ. Microbiol. 71:6554-6563.  
 
Loretz, M., R. Stephan, and C. Zweifel. 2010. Antimicrobial activity of decontamination 
treatments for poultry carcasses: a literature survey. Food Control 21:791-804.  
 
Luber, P. 2009. Cross-contamination versus undercooking of poultry meat or eggs—which risks 
need to be managed first? Int. J. Food Microbiol. 134:21-28.  
 
Manfreda, G., A. De Cesare, V. Bondioli, N. J. Stern, and A. Franchini. 2006. Enumeration and 
identity of Campylobacter spp. in Italian broilers. Poult. Sci. 85:556-562.  
 
Mattoo, B. 1959. On the complete dissociation of 2, 4-dihydroxybenzoic (β-resorcyclic) acid. Z 
.Phys. Chem. 22:187-198.  
 
Mattson, T. E., A. K. Johny, M. A. R. Amalaradjou, K. More, D. T. Schreiber, J. Patel, and K. 
Venkitanarayanan. 2011. Inactivation of Salmonella spp. on tomatoes by plant molecules. 
Int. J. Food Microbiol. 144:464-468.  
 
McMeekin, T., and C. Thomas. 1978. Retention of bacteria on chicken skin after immersion in 
bacterial suspensions. J. Appl. Bacteriol. 45:383-387.  
 
Mead, P. S., L. Slutsker, V. Dietz, L. F. McCaig, J. S. Bresee, C. Shapiro, P. M. Griffin, and R. 
V. Tauxe. 1999. Food-related illness and death in the United States. Emerg. Infect. Dis. 
5:607-625. 
 
Metcalf, J. H., A. M. Donoghue, K. Venkitanarayanan, I. Reyes-Herrera, V. F. Aguiar, P. J. 
Blore, and D. J. Donoghue. 2011. Water administration of the medium-chain fatty acid 
caprylic acid produced variable efficacy against enteric Campylobacter colonization in 
broilers. Poult. Sci. 90:494-497.  
 
Milne, M. 1965. Influence of acid-base balance on efficacy and toxicity of drugs. Proc. R. Soc. 
Med. 58:961.  
 
Milne, M. D., B. H. Scribner, and M. A. Crawford. 1958. Non-ionic diffusion and the excretion 
of weak acids and bases. Am. J. Med. 24:709-729.  
 
Molatová, Z., E. Skřivanová, J. Baré, K. Houf, G. Bruggeman, and M. Marounek. 2011. Effect 
of coated and non‐coated fatty acid supplementation on broiler chickens experimentally 
infected with Campylobacter jejuni. J. Anim. Physiol. Anim. Nutr. 95:701-706.  
 
Morishita, T. Y., P. P. Aye, B. S. Harr, C. W. Cobb, and J. R. Clifford. 1997. Evaluation of an 
avian-specific probiotic to reduce the colonization and shedding of Campylobacter jejuni 
in broilers. Avian Dis. :850-855.  
 
73 
 
Morrison, G., and G. Fleet. 1985. Reduction of Salmonella on chicken carcasses by immersion 
treatments. J. Food Prot. 48.  
 
Musavian, H. S., N. H. Krebs, U. Nonboe, J. E. Corry, and G. Purnell. 2014. Combined steam 
and ultrasound treatment of broilers at slaughter: A promising intervention to 
significantly reduce numbers of naturally occurring Campylobacters on carcasses. Int. J. 
Food Microbiol. 176:23-28.  
 
Nesheim, M. C., and J. D. Garlich. 1963. Studies on ornithine synthesis in relation to benzoic 
acid excretion in the domestic fowl. J. Nutr. 79:311-317.  
 
Newell, D. G., K. T. Elvers, D. Dopfer, I. Hansson, P. Jones, S. James, J. Gittins, N. J. Stern, R. 
Davies, I. Connerton, D. Pearson, G. Salvat, and V. M. Allen. 2011. Biosecurity-based 
interventions and strategies to reduce Campylobacter spp. on poultry farms. Appl. 
Environ. Microbiol. 77:8605-8614.  
 
Notermans, S., and E. Kampelmacher. 1974. Attachment of some bacterial strains to the skin of 
broiler chickens. Br. Poult. Sci. 15:573-585.  
 
Park, H., Y.-C. Hung, and R. E. Brackett. 2002. Antimicrobial effect of electrolyzed water for 
inactivating Campylobacter jejuni during poultry washing. Int. J. Food Microbiol. 72:77-
83.  
 
Patterson, M. 1995. Sensitivity of Campylobacter spp. to irradiation in poultry meat. Lett. Appl. 
Microbiol. 20:338-340.  
 
Perkins, C. 2012. US restricts antibiotics for livestock in Global Meat news.com, United States. 
Accessed Sep. 2014. 
 
Reich, F., V. Atanassova, E. Haunhorst, and G. Klein. 2008. The effects of Campylobacter 
numbers in caeca on the contamination of broiler carcasses with Campylobacter. Int. J. 
Food Microbiol. 127:116-120.  
 
Rhodes, K. M., and A. E. Tattersfield. 1982. Guillain-Barré syndrome associated with 
Campylobacter infection. Br. Med. J. 285:173-174.  
 
Riedel, C. T., L. Brøndsted, H. Rosenquist, S. N. Haxgart, and B. B. Christensen. 2009. 
Chemical decontamination of Campylobacter jejuni on chicken skin and meat. J. Food 
Prot. 72:1173-1180.  
 
Robyn, J., G. Rasschaert, D. Hermans, F. Pasmans and M. Heyndrickx. 2013. Is allicin able to 
reduce Campylobacter jejuni colonization in broilers when added to drinking water? Poult. 
Sci. 92:1408-1418. 
 
74 
 
Rosenquist, H., N. L. Nielsen, H. M. Sommer, B. Nørrung, and B. B. Christensen. 2003. 
Quantitative risk assessment of human campylobacteriosis associated with thermophilic 
Campylobacter species in chickens. Int. J. Food Microbiol. 83:87-103.  
 
Samuel, M. C., D. J. Vugia, S. Shallow, R. Marcus, S. Segler, T. McGivern, H. Kassenborg, K. 
Reilly, M. Kennedy, F. Angulo, R. V. Tauxe, and G. for the Emerging Infections 
Program FoodNet Working. 2004. Epidemiology of Sporadic Campylobacter Infection in 
the United States and Declining Trend in Incidence, FoodNet 1996–1999. Clin. Infect. 
Dis. 38:S165-S174.  
 
Scallan, E., R. M. Hoekstra, F. J. Angulo, R. V. Tauxe, M.-A. Widdowson, S. L. Roy, J. L. 
Jones, and P. M. Griffin. 2011. Foodborne illness acquired in the United States--major 
pathogens. Emerg. Infect. Dis. 17.  
 
SCVPH. 1998. Report of the Scientific Committee on Veterinary Measures relating to Public 
Health (SCVPH) on benefits and limitations of antimicrobial treatments for poultry 
carcasses. Accessed Nov. 2014. 
 
Skirrow, M. B. 1991. Epidemiology of Campylobacter enteritis. Int. J. Food Microbiol. 12:9-16. 
 
Solis de Los Santos, F. S., M. Hume, K. Venkitanarayanan, A. M. Donoghue, I. Hanning, M. F. 
Slavik, V. F. Aguiar, J. H. Metcalf, I. Reyes-Herrera, and P. J. Blore. 2010. Caprylic acid 
reduces enteric Campylobacter colonization in market-aged broiler chickens but does not 
appear to alter cecal microbial populations. J. Food Prot. 73:251-257.  
 
Spiller, R. C. 2007. Role of infection in irritable bowel syndrome. J. Gastroenterol. 42:41-47.  
 
Stern, N. J., J. S. Bailey, L. C. Blankenship, N. A. Cox, and F. McHan. 1988. Colonization 
characteristics of Campylobacter jejuni in chick ceca. Avian Dis. 32:330-334. 
  
Stern, N. J., P. Fedorka-Cray, J. S. Bailey, N. A. Cox, S. E. Craven, K. L. Hiett, M. T. Musgrove, 
S. Ladely, D. Cosby, and G. C. Mead. 2001. Distribution of Campylobacter spp. in 
selected U.S. poultry production and processing operations. J. Food Prot. 64:1705-1710.  
 
Stern, N. J., E. A. Svetoch, B. V. Eruslanov, Y. N. Kovalev, L. I. Volodina, V. V. Perelygin, E. 
V. Mitsevich, I. P. Mitsevich, and V. P. Levchuk. 2005. Paenibacillus polymyxa purified 
bacteriocin to control Campylobacter jejuni in chickens. J. Food Prot. 68:1450-1453.  
 
Svetoch, E. A., and N. J. Stern. 2010. Bacteriocins to control Campylobacter spp. in poultry-A 
review. Poult. Sci. 89:1763-1768.  
 
Thomas, C. J., and T. A. McMeekin. 1982. Effect of water immersion on the microtopography of 
the skin of chicken carcasses. J. Sci. Food Agric. 33:549-554.  
 
Thormar, H., H. Hilmarsson, J. Thrainsson, F. Georgsson, E. Gunnarsson, and S. Dadadottir. 
2011. Treatment of fresh poultry carcases with emulsions of glycerol monocaprate 
75 
 
(monocaprin) to reduce contamination with Campylobacter and psychrotrophic bacteria. 
Br. Poult. Sci. 52:11-19.  
 
Upadyaya, I. 2014. Effect of β –resorcylic acid and chitosan on reducing Salmonella Enteritidis 
colonization in 21-day-old broiler chicks. Poster no. 502, PSA 2014. 
 
Wagenaar, J. A., M. A. Van Bergen, M. A. Mueller, T. M. Wassenaar, and R. M. Carlton. 2005. 
Phage therapy reduces Campylobacter jejuni colonization in broilers. Vet. Microbiol. 
109:275-283.  
 
World Health Organization. 2012. The global view of Campylobacteriosis. Accessed 5/30, 2014. 
 
Whyte, P., K. McGill, and J. Collins. 2003. An assessment of steam pasteurization and hot water 
immersion treatments for the microbiological decontamination of broiler carcasses. Food 
Microbiol. 20:111-117.  
 
Widders, P. R., R. Perry, W. I. Muir, A. J. Husband, and K. A. Long. 1996. Immunisation of 
chickens to reduce intestinal colonisation with Campylobacter jejuni. Br. Poult. Sci. 
37:765-778.  
 
Wong, T. L., L. Hollis, A. Cornelius, C. Nicol, R. Cook, and J. A. Hudson. 2007. Prevalence, 
numbers, and subtypes of Campylobacter jejuni and Campylobacter coli in uncooked 
retail meat samples. J. Food Prot. 70:566-573.  
 
Woo-Ming, A. 2012. Feed supplementation with natural extracts of cranberry and its efficacy on 
Campylobacter colonization in poultry. Master thesis. University of Arkansas, United 
States. 
 
Zhao, T., and M. P. Doyle. 2006. Reduction of Campylobacter jejuni on chicken wings by 
chemical treatments. J. Food Prot. 69:762-767.  
  
76 
 
Table 1: The effect of different concentrations of BR on cecal Campylobacter counts (Log 
CFU/g of cecal content) in 14 days old broiler chickens (Mean ± SEM)1. 
Treatments Trial 1 Trial 2 
Campylobacter Control 7.47 ± 0.28ab 7.27  ± 0.42ab 
β-resorcylic acid          
0.25% 
 
8.04 ± 0.21a 
 
5.50 ± 1.22abc 
0.5% 6.82 ± 0.46bc 3.03 ± 0.88d 
0.75% - 7.61 ± 0.44a 
1% 6.90 ± 0.18bc 4.47 ± 0.92cd 
1.5% - 5.22 ± 0.81bcd 
2% 6.09 ± 0.48c 7.74 ± 0.46a 
a, b, c Means within columns with no common superscripts differ significantly (P<0.05). 
1Chicks were fed with BR in all groups except Campylobacter controls (0% BR) from day old 
hatch to the end of 14-day studies in both the trials. On day 7, birds were challenged via orally 
gavage (0.25mL/birds) with approximately 1×106 CFU/mL of mixture of four wild strains of 
Campylobacter jejuni. Campylobacter data were Log10 transformed for statistical analysis. 
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Table 2: The effect of different concentrations of BR on body weight gain (Mean ± SEM) and 
feed consumption (g/bird) in 14 days old broiler chickens1. 
 Trial 1 Trial 2 
 Body weight 
gain (g) 
Feed 
consumption (g) 
Body weight 
gain (g) 
Feed 
consumption (g) 
Positive Control 325.68±14.08a 502.3 263.06±27.58ab 735.9 
β-resorcylic acid      
0.25% 279.67±27.17ab 622.2 269.33±21.45ab 604.4 
0.5% 253.74±23.34bc 518.4 283.87±24.51a 546.2 
0.75% - - 288.53±20.10a 620.6 
1% 228.40±21.93bc 624.8 310.53±20.37a 650 
1.5% - - 207.6±24.51bc 650.7 
2% 212.63±4.43c 438.8 150.99±24.82c 575.2 
a, b, c Means within columns with no common superscripts differ significantly (P<0.05). 
1Chicks were fed with BR in feed in all groups except control from day old hatch to the end of 
14-day studies in both the trials. 
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Figure 1: The effect of different concentrations (20, 30, 40, 50, 60, 70, and 75mM) of BR on in 
vitro growth of Campylobacter jejuni in cecal material (Mean ± SEM).  
 
 
a, b, c Means within hours with no common superscripts differ significantly (P<0.05). All 
Campylobacter data were Log10 transformed for statistical analysis. 
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Figure 2: The effect of different concentrations of BR on chicken meat samples (2±0.1g) 
challenged with approximately 1.7×107 CFU/mL of four wild strains of Campylobacter jejuni 
(Mean ± SEM).  
 
 
 
a, b, c, d Means within trials with no common superscripts differ significantly (P<0.05). All 
Campylobacter data were Log10 transformed for statistical analysis (n=10 samples/dose). 
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Figure 3: The effect of different concentrations (in percentage) of BR on chicken skin samples 
(2±0.1g) challenged with approximately 2.4×107 CFU/mL of four wild strains of Campylobacter 
jejuni (Mean ± SEM).  
 
a, b, c Means within trials with no common superscripts differ significantly (P<0.05). All 
Campylobacter data were Log10 transformed for statistical analysis (n=10 samples/dose).  
 
 
 
1
2
3
4
5
6
C
a
m
p
yl
o
b
a
ct
er
co
u
n
ts
L
o
g
 C
F
U
/g
 o
f 
sk
in
 s
a
m
p
le
β-resorcylic acid 
a
b b
b
a
b
b
0.5% 1% 2% 0%
c
0% 0.5% 1% 2% 
Trial 1 Trial 2 
81 
 
 
  
82 
 
  
83 
 
  
 
  
 
 
84 
 
CONCLUSION 
Campylobacteriosis is one of the leading foodborne illnesses in United States, and is 
associated with the consumption of poultry and poultry products. Reducing Campylobacter in 
these species will reduce the burden of this disease. Unfortunately, most strategies employed to 
reduce Campylobacter in chicken have either not been successful or produced inconsistent 
results. One potential control strategy is the use of β-resorcylic acid (BR), a phytophenolic 
compound classified by the US FDA as “Everything Added to Food in the United States” (EAF 
3045) and is therefore deemed safe for consumption. This compounds has antibacterial activity 
against Salmonella, however, its efficacy to control Campylobacter in poultry has not been 
evaluated. Preliminary studies in our laboratory demonstrated that BR kills Campylobacter 
jejuni, in vitro. Therefore, the objective of this study was to evaluate whether BR would reduce 
Campylobacter in chickens. In pre-harvest studies, day of hatch chicks were fed one of five 
treatments (0, 0.25, 0.5, 1 or 2%BR) in the first trial, whereas a second trial was conducted 
including two additional doses of 0.75% & 1.5% BR (n=10 chicks/dose). Birds were challenged 
with mixture of four wild strains of C. jejuni (~ 106CFU/mL) on day 7 and cecal samples were 
collected on day 14 and enumerated for Campylobacter. In post-harvest studies four trials, two 
each on thigh skin and breast meat, were conducted. Chicken skin or meat samples (2±0.1g) 
were inoculated with 50µL of C. jejuni (~ 107 CFU/mL). Following 30 min of attachment, 
samples were dipped into their respective treatment solutions (0, 0.5, 1, 2% BR) for 30 s and 
suspended 2 min (n=10 samples/dose) and evaluated for reduction in Campylobacter counts. 
Data were analyzed by PROC GLM procedure of SAS (P < 0.05). Campylobacter counts were 
reduced by 1.4 Log CFU/g for the 2% dose in the first pre-harvest trial and by 4.2 or 2.8 Log 
CFU/g for the 0.5 % & 1% BR doses in the second pre-harvest trial.  In the post-harvest studies, 
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all doses of BR significantly reduced Campylobacter counts in both meat and skin. Results of 
these experiments suggest post-harvest application of BR is the most effective treatment and may 
help reduce the incidence of human campylobacteriosis. 
 
